<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?DTDIdentifier.IdentifierValue -//ES//DTD journal article DTD version 5.6.0//EN//XML?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName art560.dtd?><?SourceDTD.Version 5.6.0?><?ConverterInfo.XSLTName elsevier2nlmx2.xsl?><?ConverterInfo.Version 1?><?origin publisher?><?FILEmeta_HLY6001 xml ?><?FILEmain xml ?><?FILEmain pdf ?><?FILEgr1 jpg ?><?FILEgr2 jpg ?><?FILEgr3 jpg ?><?FILEgr4 jpg ?><?FILEgr5 jpg ?><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Heliyon</journal-id><journal-id journal-id-type="iso-abbrev">Heliyon</journal-id><journal-title-group><journal-title>Heliyon</journal-title></journal-title-group><issn pub-type="epub">2405-8440</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7833933</article-id><article-id pub-id-type="pii">S2405-8440(21)00106-7</article-id><article-id pub-id-type="doi">10.1016/j.heliyon.2021.e06001</article-id><article-id pub-id-type="publisher-id">e06001</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Potential compounds from several Indonesian plants to prevent SARS-CoV-2 infection: A mini-review of SARS-CoV-2 therapeutic targets</article-title></title-group><contrib-group><contrib contrib-type="author" id="au1"><name><surname>Illian</surname><given-names>Didi Nurhadi</given-names></name><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="au2"><name><surname>Siregar</surname><given-names>Etti Sartina</given-names></name><xref rid="aff2" ref-type="aff">b</xref><xref rid="aff7" ref-type="aff">g</xref></contrib><contrib contrib-type="author" id="au3"><name><surname>Sumaiyah</surname><given-names>Sumaiyah</given-names></name><xref rid="aff3" ref-type="aff">c</xref></contrib><contrib contrib-type="author" id="au4"><name><surname>Utomo</surname><given-names>Ahmad Rusdan</given-names></name><xref rid="aff4" ref-type="aff">d</xref><xref rid="aff5" ref-type="aff">e</xref></contrib><contrib contrib-type="author" id="au5"><name><surname>Nuryawan</surname><given-names>Arif</given-names></name><xref rid="aff6" ref-type="aff">f</xref><xref rid="aff7" ref-type="aff">g</xref></contrib><contrib contrib-type="author" id="au6"><name><surname>Basyuni</surname><given-names>Mohammad</given-names></name><email>m.basyuni@usu.ac.id</email><xref rid="aff6" ref-type="aff">f</xref><xref rid="aff7" ref-type="aff">g</xref><xref rid="cor1" ref-type="corresp">&#x02217;</xref></contrib><aff id="aff1"><label>a</label>Department of Pharmacy, Faculty of Mathematics and Natural Science, Universitas Syiah Kuala, Banda Aceh, 23111, Indonesia</aff><aff id="aff2"><label>b</label>Department of Biology, Faculty of Mathematics and Natural Sciences, Universitas Sumatera Utara, Medan, 20155, Indonesia</aff><aff id="aff3"><label>c</label>Department of Technology Pharmacy, Faculty of Pharmacy, Universitas Sumatera Utara, Medan, 20155, Indonesia</aff><aff id="aff4"><label>d</label>Senior Molecular Testing Laboratory Consultant at Clinical Lab Advisor, Indonesia</aff><aff id="aff5"><label>e</label>Perhimpunan Biologi Medik Indonesia PBMI, Indonesia</aff><aff id="aff6"><label>f</label>Department of Forestry, Faculty of Forestry, Universitas Sumatera Utara, Medan, 20155, Indonesia</aff><aff id="aff7"><label>g</label>Center of Excellence for Mangrove, Universitas Sumatera Utara, Medan, 20155, Indonesia</aff></contrib-group><author-notes><corresp id="cor1"><label>&#x02217;</label>Corresponding author. <email>m.basyuni@usu.ac.id</email></corresp></author-notes><pub-date pub-type="pmc-release"><day>16</day><month>1</month><year>2021</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="collection"><month>1</month><year>2021</year></pub-date><pub-date pub-type="epub"><day>16</day><month>1</month><year>2021</year></pub-date><volume>7</volume><issue>1</issue><elocation-id>e06001</elocation-id><history><date date-type="received"><day>12</day><month>11</month><year>2020</year></date><date date-type="rev-recd"><day>31</day><month>12</month><year>2020</year></date><date date-type="accepted"><day>13</day><month>1</month><year>2021</year></date></history><permissions><copyright-statement>&#x000a9; 2021 The Author(s)</copyright-statement><copyright-year>2021</copyright-year><license license-type="CC BY-NC-ND" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/"><license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p></license></permissions><abstract id="abs0010"><p>The outbreak of coronaviruses (CoVs) presents an enormous threat to humans. To date, no new therapeutic drugs or vaccines licensed to treat human coronaviruses remain undiscovered. This mini-review briefly reports the number of potential plants widely distributed in Indonesia for further research and development as anti-SARS-CoV-2 agents and the critical targets for SARS-CoV-2 therapy, such as angiotensin-converting enzyme 2 (ACE-2) receptor, spike protein, 3-chymotrypsin-like protease (3CL<sup>pro</sup>), papain-like protease (PL<sup>pro</sup>), RNA-dependent RNA polymerase (RdRp), helicase, and serine protease. Indonesia is rich in medicinal plants (herbal); it also has a long history of using plants to treat various hereditary diseases. However, since SARS-CoV-2 is a new disease, it has no history of plant-based treatment anywhere in the world. This mini-review describes natural products from several Indonesian plants that contain compounds that could potentially prevent or reduce SARS-CoV-2 infection, act as potential targeted therapy, and provide new therapeutic strategies to develop SARS-CoV-2 countermeasures.</p></abstract><abstract abstract-type="teaser" id="abs0015"><p>COVID-19; SARS-CoV-2; Therapeutic target; Emodin; Luteolin; Mangroves.</p></abstract><kwd-group id="kwrds0010"><title>Keywords</title><kwd>COVID-19</kwd><kwd>SARS-CoV-2</kwd><kwd>Therapeutic target</kwd><kwd>Emodin</kwd><kwd>Luteolin</kwd><kwd>Mangroves</kwd></kwd-group></article-meta></front><body><sec id="sec1"><label>1</label><title>Introduction</title><p id="p0010">CoVs are a family of positive-stranded RNA viruses that cause life-threatening breathing infections and severe pneumonia in humans (which resulted in a significant epidemic only two decades ago). Presently, three single-stranded RNA (ssRNA) beta-coronaviruses, including SARS (severe acute respiratory syndrome) virus, MERS (Middle East respiratory syndrome) virus, and SARS-CoV-2, have been detected (<xref rid="bib49" ref-type="bibr">Masters, 2006</xref>; <xref rid="bib23" ref-type="bibr">Gorbalenya et&#x000a0;al., 2020</xref>; <xref rid="bib34" ref-type="bibr">Huang et&#x000a0;al., 2020</xref>).</p><p id="p0015">The World Health Organization (WHO) designated the coronavirus discovered in 2019 as 2019-novel coronavirus or SARS-CoV-2. It has been reported that SARS-CoV-2 is exceptionally homologous to SARS-CoV. Therefore, SARS-CoV-2 is believed to be a close relative of SARS-CoV. Accordingly, the International Virus Classification Commission (ICTV) identified SARS-CoV-2 as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and concurrently, the WHO recognized the disease generated by 2019-nCoV as COVID-19 (<xref rid="bib90" ref-type="bibr">Zhu et&#x000a0;al., 2020</xref>; <xref rid="bib15" ref-type="bibr">Chen et&#x000a0;al., 2020a</xref>, <xref rid="bib16" ref-type="bibr">b</xref>). At the time this mini-review was written, the number of confirmed cases was 5,488,825, with a mortality rate of 349,095 people in 217 countries or territories (<xref rid="bib78" ref-type="bibr">WHO, 2020</xref>).</p><p id="p0020">The Department of Clinical Microbiology, Faculty of Medicine, Universitas Indonesia, conducted a preliminary analysis on COVID-19 cases in Indonesia. The Laboratory of Clinical Microbiology (one of the reference laboratories for COVID-19 specimens) received 4167 specimens from March to April 2020, with 582 specimens showing positive results, indicating that the positivity rate was 12.6%. Demographic data revealed that the average age of COVID-19-positive patients was 44.5 years, with an age range of 2&#x02013;85 years, and 59% were male. Approximately 17% of patients had comorbidities, predominantly cardiovascular disease (58%) and diabetes (37%). The average age of the COVID-19-positive patients reported in that work was similar to that reported in the Singapore case data (42.5 years) but younger than that reported in Wuhan (55.5 years). However, the findings that male sex and cardiovascular disease are COVID-19 comorbidities are concordant with previous studies from other countries (<xref rid="bib35" ref-type="bibr">Ibrahim et&#x000a0;al., 2020</xref>).</p><p id="p0025">Moreover, 8% of the positive patients with COVID-19 were health workers. Another surprising finding was that approximately 22% of COVID-19 patients were asymptomatic, and 34% had mild symptoms, with the remaining 44% exhibiting moderate to serious signs. Although respiratory symptoms are common in patients with COVID-19 (found in 73% of cases), it has been shown that nonspecific symptoms of COVID-19, such as gastrointestinal complaints, lethargy and headaches, cannot be excluded. This fact should definitely be considered due to the transmission risk (<xref rid="bib35" ref-type="bibr">Ibrahim et&#x000a0;al., 2020</xref>).</p><p id="p0030">SARS-CoV-2 interacts with cell surface receptors named angiotensin converting enzyme 2 (ACE-2) once it enters the cells of humans (<xref rid="bib44" ref-type="bibr">Li et&#x000a0;al., 2003</xref>; <xref rid="bib26" ref-type="bibr">Han et&#x000a0;al., 2006</xref>; <xref rid="bib22" ref-type="bibr">Ge et&#x000a0;al., 2013</xref>). The penetration of the virus into the human body triggers an immune system reaction with the aim of eliminating the virus. The working immune system consists of various cells, including macrophage cells, neutrophil cells, lymphocytes, dendrite cells, etc., which produce cytokines. These cytokines activate cells and trigger further mechanisms that elicit symptoms of the disease. Example mechanisms in the lungs (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>): S-ACE2 protein binding leads to viral entry &#x02013; triggers the immune system: (1) Endothelial cell damage occurs, and fluid from the blood vessels enters the alveoli of the lungs, causing symptoms. (2) The damaged endothelium triggers the coagulation system (blood clotting), and a blood clot can form, which is carried through the bloodstream and causes blockage of the blood vessels. (3) An inflammatory reaction (inflammation) occurs, which induces the production of cytokines and leads to a cytokine storm (<xref rid="bib74" ref-type="bibr">Teuwen et&#x000a0;al., 2020</xref>).<fig id="fig1"><label>Figure&#x000a0;1</label><caption><p>Pathomechanism of the lungs (adapted from <xref rid="bib74" ref-type="bibr">Teuwen et&#x000a0;al., 2020</xref> with permission).</p></caption><alt-text id="alttext0010">Figure&#x000a0;1</alt-text><graphic xlink:href="gr1"/></fig></p><p id="p0035">Example mechanisms in the heart (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>): S-ACE2 protein binding leads to viral entry &#x02013; triggers the immune system: Cytokines are released by macrophages, causing damage to endothelial cells and pericytes, as well as myocyte damage. The resulting damage can lead to myocarditis, acute coronary syndrome, arrhythmia, and heart failure. The symptoms are the same as those of a heart attack (<xref rid="bib24" ref-type="bibr">Guzik et&#x000a0;al., 2020</xref>) and can be mild, moderate, or severe, depending on the amount of cytokines formed. The more cytokines that are formed, the more severe the symptoms will be (illustration in <xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>) (<xref rid="bib88" ref-type="bibr">Zhou et&#x000a0;al., 2020a</xref>, <xref rid="bib89" ref-type="bibr">b</xref>).<fig id="fig2"><label>Figure&#x000a0;2</label><caption><p>Pathomechanism of the heart (adapted <xref rid="bib24" ref-type="bibr">Guzik et&#x000a0;al., 2020</xref> with permission).</p></caption><alt-text id="alttext0015">Figure&#x000a0;2</alt-text><graphic xlink:href="gr2"/></fig><fig id="fig3"><label>Figure&#x000a0;3</label><caption><p>Cytokine formation related to the severity of COVID-19 symptoms (adapted from <xref rid="bib88" ref-type="bibr">Zhou et&#x000a0;al., 2020a</xref>, <xref rid="bib89" ref-type="bibr">b</xref> with permission).</p></caption><alt-text id="alttext0020">Figure&#x000a0;3</alt-text><graphic xlink:href="gr3"/></fig></p><p id="p0040">There are two therapeutic possibilities for anti-coronavirus therapy (depending on the target): enhancing the human immune system (human cells) and attacking the coronavirus itself. The innate immune response is associated with the human immune system and helps to control the infection by preventing coronavirus replication (<xref rid="bib56" ref-type="bibr">Omrani et&#x000a0;al., 2014</xref>). If the human cell signaling pathways required for virus replication can be blocked, a certain antiviral effect could be achieved.</p><p id="p0045">Coronavirus therapies include preventing viral RNA synthesis through the use of genetic virus material to prevent replication by acting on critical virus enzymes and preventing the binding of virus to human cells (ACE-2 receptor and spike protein) or inhibiting the process of self-assembly of the virus by acting on certain structural proteins, including viral papain-like protease (PL<sup>pro</sup>), main protease (M<sup>pro</sup>/3CL<sup>pro</sup>, also recognized 3-chymotrypsin-like protease), RNA-dependent RNA polymerase (RdRp), helicase, and serine protease (<xref rid="bib87" ref-type="bibr">Yu et&#x000a0;al., 2012</xref>; <xref rid="bib19" ref-type="bibr">Clemente et&#x000a0;al., 2019</xref>; <xref rid="bib80" ref-type="bibr">Wu et&#x000a0;al., 2020</xref>).</p><p id="p0050">Presently, <italic>in silico</italic> (computational model) techniques are being used to identify plant compounds that can prevent SARS-CoV-2 infection and replication by predicting their activity against disease targets (<xref rid="bib25" ref-type="bibr">Gyebi et&#x000a0;al., 2020</xref>). For example, methoxyflavonoid compounds such as hesperetin, tangerine, naringenin, and nobiletin have been identified in oranges (<italic>Citrus sp.</italic>; fruit and skin) (<xref rid="bib65" ref-type="bibr">Singh et&#x000a0;al., 2020</xref>; <xref rid="bib75" ref-type="bibr">Utomo et&#x000a0;al., 2020</xref>), and baikalin, scutellarin, glycyrrhizin, rhoifolin, herbacetin, pectolinarin and galangin compounds have been identified in galangal (<italic>Alpinia galanga</italic>; rhizome) (<xref rid="bib73" ref-type="bibr">Tang et&#x000a0;al., 2018</xref>; <xref rid="bib29" ref-type="bibr">Haslberger et&#x000a0;al., 2020</xref>; <xref rid="bib75" ref-type="bibr">Utomo et&#x000a0;al., 2020</xref>).</p><p id="p0055">The similarity of the SARS-CoV-2 virus gene sequences with SARS-CoV reaches 79.5%, and the similarity in the manner in which the virus enters humans and passes through the ACE-2 receptor suggests common therapeutic targets (<xref rid="bib36" ref-type="bibr">Jia et&#x000a0;al., 2005</xref>; <xref rid="bib88" ref-type="bibr">Zhou et&#x000a0;al., 2020a</xref>, <xref rid="bib89" ref-type="bibr">b</xref>). The chemical content (compounds) of some plants has been widely studied, and their activity related to SARS-CoV therapy has been documented, which will speed up evaluations of the activity of these compounds against SARS-CoV-2. Some Indonesian plants contain active compounds that could restrict SARS-CoV-2 infection and replication based on their activity against relevant therapeutic targets. Potentially active compounds have been found in vegetables, crops, and mangroves (Indonesian plants) and show activity (binding) against protein targets such as RBD-S, PD-ACE2, and SARS-CoV-2 protease. These compounds (i.e., hesperidin, flavonoids, curcumin, brazilin, and galangin), show the potential for development as SARS-CoV-2 inhibitors that could be applied in daily life as prophylaxis for COVID-19 (<xref rid="bib6" ref-type="bibr">Amin et&#x000a0;al., 2019</xref>; <xref rid="bib8" ref-type="bibr">Azminah et&#x000a0;al., 2019</xref>; <xref rid="bib75" ref-type="bibr">Utomo et&#x000a0;al., 2020</xref>).</p></sec><sec id="sec2"><label>2</label><title>Method</title><p id="p0060">Data on COVID-19, herbal medicine and dietary therapy were searched and collected for this miniature review and perspective. We used key search engines, namely, Google Scholar, PubMed, Science Direct and SciFinder. The search keywords used comprised coronavirus; etiology; signs; symptoms; allopathic therapy adjacent to COVID-19; immunomodulatory and anti-influenza herbal activity, SARS-CoV-1, and SARS-CoV-2. The authors appraised, evaluated, and interpreted the selected articles. This perspective reflects the opinion of the authors concerning the use of foods and herbs as preventatives and corresponding therapies against COVID-19.</p></sec><sec id="sec3"><label>3</label><title>Targets for blocking the viral entry point</title><sec id="sec3.1"><label>3.1</label><title>Angiotensin-converting enzyme 2 (ACE-2)</title><p id="p0065">ACE-2 is a receptor that has been confirmed as the entry point for the SARS-CoV-2 virus to infect human cells. Scientists suggest a strong interaction exists between human ACE-2 molecules and SARS-CoV-2 (<xref rid="bib84" ref-type="bibr">Xu et&#x000a0;al., 2020</xref>). ACE-2 receptors are widely present in lung cells (especially lung endothelial cells) and in large numbers in type II alveolar cells in the lungs, epithelial cells in the upper esophagus, enterocytes in the ileum (the last part of the small intestine) and colon (large intestine), epithelial cells in the bile, heart muscle cells, proximal tubules in the kidneys, and urothelial cells in the bladder (<xref rid="bib93" ref-type="bibr">Zou et&#x000a0;al., 2020</xref>), meaning that the SARS CoV-2 virus can attack any organ that has ACE-2 receptors. Symptoms that arise based on the target organ are as follows: in the lungs, it causes shortness&#x02013;edema&#x02013;respiratory failure; in the blood, it causes a reduction in the number of blood cells&#x02013;coagulopathy; in the kidneys, it causes renal failure; and in the heart, it causes tachycardia&#x02013;arrhythmia and heart failure (<xref rid="fig4" ref-type="fig">Figure&#x000a0;4</xref>) (<xref rid="bib88" ref-type="bibr">Zhou et&#x000a0;al., 2020a</xref>, <xref rid="bib89" ref-type="bibr">b</xref>). ACE-2 is an integral membrane protein type I with an active site domain uncovered outside the cells and has been described in receptor function studies of SARS-CoV-2 (<xref rid="bib38" ref-type="bibr">Kuhn et&#x000a0;al., 2006</xref>). The virus starts the infection by spike protein (S-protein) binding between SARS-CoV-2 and ACE-2 in the host cell (<xref rid="bib76" ref-type="bibr">Walls et&#x000a0;al., 2020</xref>). The interaction of ACE-2 and the viral S-protein enables SARS-CoV-2 to enter the circulation (<xref rid="bib9" ref-type="bibr">Belouzard et&#x000a0;al., 2009</xref>). The SARS-CoV-2 receptor-binding domain (RBD) successfully interacts human ACE2-expressing cells but not with any other receptors, ensuring that in the future, human ACE-2 will be required by the newly evolving SARS-CoV-2 for cell entry (<xref rid="bib32" ref-type="bibr">Hoffmann et&#x000a0;al., 2020</xref>; <xref rid="bib41" ref-type="bibr">Letko et&#x000a0;al., 2020</xref>).<fig id="fig4"><label>Figure&#x000a0;4</label><caption><p>Signs and symptoms of SARS CoV-2 virus in organs that have ACE-2 receptors (adapted from <xref rid="bib88" ref-type="bibr">Zhou et&#x000a0;al., 2020a</xref>, <xref rid="bib89" ref-type="bibr">b</xref> with permission).</p></caption><alt-text id="alttext0025">Figure&#x000a0;4</alt-text><graphic xlink:href="gr4"/></fig></p><p id="p0070">This infection risk can be prevented or reduced with plant compounds that can interfere with these interactions. Molecular docking studies have shown that baicalin might bind strongly to the ACE-2 enzyme with an expected &#x00394;G (kcal/mol) of &#x02013;8.46 and potential binding sites at ASN-149, ARG-273, and HIS-505. These binding sites are situated in the hydrophobic area of ACE-2. Based on the potential binding to ACE-2, it can be suggested that baicalin is a promising candidate for 2019-nCoV treatment. Furthermore, molecular docking found that scutellarin has the potential to bind to ACE-2 with a projected &#x00394;G (kcal/mol) of &#x02013;14.9 and binding sites at GLU-495, UNK-957, and ARG-482 (<xref rid="bib14" ref-type="bibr">Chen and Du, 2020</xref>). The molecular docking studies of hesperidin with the ACE-2 enzyme demonstrated that hesperidin can bind to ACE-2 with a predicted &#x00394;G (kcal/mol) of &#x02013;8.3 and binding sites at TYR-613, SER-611, ARG-482, and GLU-479 (<xref rid="bib14" ref-type="bibr">Chen and Du, 2020</xref>). These results suggest that hesperidin may bind to ACE-2 and thus block 2019-nCoV infection.</p><p id="p0075">A previous study (<xref rid="bib71" ref-type="bibr">Takahashi et&#x000a0;al., 2015</xref>) demonstrated that nicotianamine is a powerful inhibitor of ACE-2, with an IC<sub>50</sub> value of 84 nM. The molecular docking studies of nicotinamine to the ACE-2 enzyme showed that nicotinamine has a promising binding affinity to ACE-2, with an approximate &#x00394;G (kcal/mol) of &#x02013;5.1 and binding sites at ARG-518, GLU-406, SER-409, GLN-522, and GLN-442. These results indicate that nicotinamine might block 2019-nCoV infection by inhibiting ACE-2 (<xref rid="bib14" ref-type="bibr">Chen and Du, 2020</xref>). The molecular docking results also showed that glycyrrhizin could bind to ACE-2 with an estimated &#x00394;G (kcal/mol) of &#x02013;9 and binding sites at ARG-559, GLN-388, ARG-393, and ASP-30. Based on the hydrophobic nature of the ACE-2 binding site, the prediction of the binding site of glycyrrhizin is near this site. GLN-388 and ARG-393 are close to the zinc metallopeptidase that might regulate the activity of ACE-2 in cells (<xref rid="bib14" ref-type="bibr">Chen and Du, 2020</xref>). The docking scores of the binding sites between natural compounds and ACE-2 of SARS-CoV-2 are presented in <xref rid="tbl1" ref-type="table">Table&#x000a0;1</xref>.<table-wrap position="float" id="tbl1"><label>Table&#x000a0;1</label><caption><p>Docking scores of the natural compounds towards the ACE-2 binding sites of SARS-CoV-2.</p></caption><alt-text id="alttext0035">Table&#x000a0;1</alt-text><table frame="hsides" rules="groups"><thead><tr><th>Plant name</th><th>Family</th><th>Plant part used</th><th>Compound name</th><th>Binding energy</th><th>Binding site</th><th>Reference</th></tr></thead><tbody><tr><td><italic>Scutellaria baicalensis</italic> Georgi.</td><td>Lamiaceae</td><td>&#x02013;</td><td>Baicalin</td><td>&#x02013;8.46</td><td>ASN-149, ARG-273, HIS-505</td><td><xref rid="bib14" ref-type="bibr">Chen and Du (2020)</xref></td></tr><tr><td><italic>Erigeron breviscapus</italic> (Vant.) Hand Mazz.</td><td>Asteraceae</td><td>&#x02013;</td><td>Scutellarin</td><td>&#x02013;14.9</td><td>GLU-495, UNK-957, ARG-482</td><td><xref rid="bib14" ref-type="bibr">Chen and Du (2020)</xref></td></tr><tr><td><italic>Citrus aurantium</italic>, <italic>Citri reticulatae</italic> Pericarpium</td><td>Rutaceae</td><td>&#x02013;</td><td>Hesperidin</td><td>&#x02013;8.3</td><td>TYR-613, SER-611, ARG-482, GLU-479</td><td><xref rid="bib14" ref-type="bibr">Chen and Du (2020)</xref></td></tr><tr><td><italic>Glycine max</italic></td><td>Leguminosae</td><td>&#x02013;</td><td>Nicotianamine</td><td>&#x02013;5.1</td><td>ARG-518, GLU-406, SER-409, GLN-522, GLN-442</td><td><xref rid="bib14" ref-type="bibr">Chen and Du (2020)</xref></td></tr><tr><td><italic>Licorice root</italic> (<italic>Glycyrrhiza radix</italic>)</td><td>Fabaceae</td><td>Herb</td><td>Glycyrrhizin</td><td>&#x02013;9</td><td>ARG-559, GLN-388, ARG-393, ASP-30</td><td><xref rid="bib14" ref-type="bibr">Chen and Du (2020)</xref></td></tr></tbody></table></table-wrap></p><p id="p0080">Several edible plants found across Indonesia contain emodin and luteolin compounds, which have the potential to prevent or reduce infection with this virus (<xref rid="tbl2" ref-type="table">Table&#x000a0;2</xref>). These compounds are capable of preventing interactions between ACE-2 receptors and the S-protein in SARS-CoV (<xref rid="bib51" ref-type="bibr">Miean and Mohamed, 2001</xref>; <xref rid="bib31" ref-type="bibr">Ho et&#x000a0;al., 2007</xref>). Edible Indonesian plants, used in folk medicine primarily in tropical regions of the world, are rich sources of emodin and include leaves of <italic>Aloe vera</italic> (L.) Burm. F. (Xanthorrhoeaceae), roots of <italic>Rheum officinale</italic> Baill. (Polygonaceae), and seeds of the genus Cassia plants such as <italic>Cassia alata</italic> L. (Fabaceae) or <italic>Senna alata</italic> (L.) Roxb. (Fabaceae), <italic>Cassia obtusifolia</italic> L. (Fabaceae) or roots of <italic>Senna obtusifolia</italic> (L.) H.S. Irwin &#x00026; Barneby (Fabaceae), <italic>Senna alexandrina</italic> Mill. (Fabaceae), and <italic>Cassia occidentalis</italic> L. (Fabaceae). Plants that contain an abundance of luteolin are the leaves and seeds of celery (<italic>Apium graveolens</italic> L., Apiaceae), the leaves and flowers of <italic>Elephantopus scaber</italic> L. (Asteraceae), and the leaves of onions (<italic>Allium cepa</italic> L., Liliaceae) and broccoli (<italic>Brassica oleracea</italic> L., Brassicaceae). Other edible plants include the fruit of chili pepper (<italic>Capsicum annuum</italic> L., Solanaceae), the leaves and fruit of <italic>Averrhoa bilimbi</italic> L. (Oxalidiaceae), the leaves of kaffir lime (<italic>Citrus hystrix</italic> D.C., Rutaceae), and the tuber of carrots (<italic>Daucuscarota</italic> L., Apiaceae). These plants are widely distributed throughout the Indonesian archipelago.<table-wrap position="float" id="tbl2"><label>Table&#x000a0;2</label><caption><p>Distribution of edible plants containing emodin or luteolin in Indonesia.</p></caption><alt-text id="alttext0040">Table&#x000a0;2</alt-text><table frame="hsides" rules="groups"><thead><tr><th>Species</th><th>Tissue</th><th>Compound</th><th>Reference</th></tr></thead><tbody><tr><td><italic>Aloe vera</italic></td><td>Leaves</td><td>Emodin</td><td>(<xref rid="bib2" ref-type="bibr">Ahlawat and Khatkar, 2011</xref>)</td></tr><tr><td><italic>Rheum officinale</italic></td><td>Roots</td><td>Emodin</td><td>(<xref rid="bib33" ref-type="bibr">Hsu and Chung, 2012</xref>); (<xref rid="bib39" ref-type="bibr">Kuo et&#x000a0;al., 2020</xref>)</td></tr><tr><td rowspan="3"><italic>Cassia alata</italic> or <italic>Senna alata</italic></td><td>Leaves, stems, fruits</td><td>Emodin</td><td>(<xref rid="bib30" ref-type="bibr">Hennebelle et&#x000a0;al., 2009</xref>); (<xref rid="bib20" ref-type="bibr">Das et&#x000a0;al., 2019</xref>)</td></tr><tr><td>Roots</td><td>Emodin</td><td>(<xref rid="bib1" ref-type="bibr">Adedoyin et&#x000a0;al., 2015</xref>)</td></tr><tr><td>Stems</td><td>Luteolin</td><td>(<xref rid="bib30" ref-type="bibr">Hennebelle et&#x000a0;al., 2009</xref>)</td></tr><tr><td><italic>Cassia obtusifolia</italic> or <italic>Senna obtusifolia</italic></td><td>Seeds</td><td>Emodin</td><td>(<xref rid="bib86" ref-type="bibr">Yang et&#x000a0;al., 2003</xref>)</td></tr><tr><td><italic>Senna alexandrina</italic></td><td>Pods</td><td>Emodin</td><td>(<xref rid="bib21" ref-type="bibr">Elkhidir et&#x000a0;al., 2012</xref>)</td></tr><tr><td><italic>Cassia occidentalis</italic></td><td>Roots</td><td>Emodin</td><td>(<xref rid="bib18" ref-type="bibr">Chukwujekwu et&#x000a0;al., 2006</xref>)</td></tr><tr><td><italic>Apium graveolens</italic></td><td>Leaves</td><td>Luteolin</td><td>(<xref rid="bib91" ref-type="bibr">Zhu and Row, 2011</xref>); (<xref rid="bib64" ref-type="bibr">Shivashri et&#x000a0;al., 2013</xref>)</td></tr><tr><td><italic>Elephantopus scaber</italic></td><td>The whole plant, aerial part, and roots</td><td>Luteolin</td><td>(<xref rid="bib92" ref-type="bibr">Zuo et&#x000a0;al., 2016</xref>); (<xref rid="bib13" ref-type="bibr">Chang et&#x000a0;al., 2011</xref>); (<xref rid="bib69" ref-type="bibr">Su et&#x000a0;al., 2009</xref>)</td></tr><tr><td><italic>Allium cepa</italic></td><td>Bulbs</td><td>Luteolin</td><td>(<xref rid="bib66" ref-type="bibr">Singh and Goel, 2015</xref>)</td></tr><tr><td><italic>Brassica oleracea</italic></td><td>Leaves</td><td>Luteolin</td><td>(<xref rid="bib51" ref-type="bibr">Miean and Mohamed, 2001</xref>); (<xref rid="bib61" ref-type="bibr">Schmidt et&#x000a0;al., 2010</xref>); (<xref rid="bib48" ref-type="bibr">Mageney et&#x000a0;al., 2017</xref>)</td></tr><tr><td><italic>Capsicum annuum</italic></td><td>Fruits</td><td>Luteolin</td><td>(<xref rid="bib51" ref-type="bibr">Miean and Mohamed, 2001</xref>); (<xref rid="bib50" ref-type="bibr">Materska et&#x000a0;al., 2015</xref>)</td></tr><tr><td><italic>Averrhoa bilimbi</italic></td><td>Fruits and leaves</td><td>Luteolin</td><td>(<xref rid="bib51" ref-type="bibr">Miean and Mohamed, 2001</xref>); (<xref rid="bib59" ref-type="bibr">Ramsay and Mueller-Harvey, 2016</xref>)</td></tr><tr><td><italic>Citrus hystrix</italic></td><td>Fruits</td><td>Luteolin</td><td>(<xref rid="bib5" ref-type="bibr">Alu'Datt et&#x000a0;al., 2017</xref>)</td></tr><tr><td><italic>Daucus carota</italic></td><td>Fruits</td><td>Luteolin</td><td>(<xref rid="bib51" ref-type="bibr">Miean and Mohamed, 2001</xref>)</td></tr></tbody></table></table-wrap></p><p id="p0085">Several studies have reported several mangrove plants that contain emodin or luteolin, as shown in <xref rid="tbl3" ref-type="table">Table&#x000a0;3</xref>. Two mangrove species, <italic>Kandelia candel</italic> and <italic>Lumnitzera racemosa</italic>, have been reported to contain emodin (<xref rid="bib81" ref-type="bibr">Wu et&#x000a0;al., 2008</xref>; <xref rid="bib46" ref-type="bibr">Liu et&#x000a0;al., 2010</xref>). In Indonesia, <italic>K.&#x000a0;candel</italic> is distributed in northeast Sumatera and west and north Kalimantan, while <italic>L.&#x000a0;racemosa</italic> is widely available throughout Indonesia (<xref rid="bib55" ref-type="bibr">Noor et&#x000a0;al., 1999</xref>). Indonesia is recognized as the major mangrove area in the world and has vast species diversity (<xref rid="bib55" ref-type="bibr">Noor et&#x000a0;al., 1999</xref>). Similarly, luteolin is found in <italic>Avicennia marina</italic> leaves and aerial roots and in mangroves and is associated with <italic>Pongamia pinnata</italic> leaves and stems (<xref rid="bib63" ref-type="bibr">Sharaf et&#x000a0;al., 2000</xref>; <xref rid="bib52" ref-type="bibr">Momtazi-borojeni et&#x000a0;al., 2013</xref>). <italic>A.&#x000a0;marina</italic> and <italic>P.&#x000a0;pinnata</italic> are found throughout Indonesia (<xref rid="bib55" ref-type="bibr">Noor et&#x000a0;al., 1999</xref>; <xref rid="bib42" ref-type="bibr">Li et&#x000a0;al., 2006</xref>; <xref rid="bib3" ref-type="bibr">Ahmed et&#x000a0;al., 2010</xref>; <xref rid="bib62" ref-type="bibr">Shamsuddin et&#x000a0;al., 2013</xref>). This potential of these raw materials opens up several non-wood functions of mangrove plants that can help reduce and prevent SARS-CoV-2 infection.<table-wrap position="float" id="tbl3"><label>Table&#x000a0;3</label><caption><p>Indonesian mangrove plants containing emodin or luteolin.</p></caption><alt-text id="alttext0045">Table&#x000a0;3</alt-text><table frame="hsides" rules="groups"><thead><tr><th>Species</th><th>Tissue</th><th>Compound</th><th>Reference</th></tr></thead><tbody><tr><td><italic>Kandelia candel</italic></td><td>Stem barks</td><td>Emodin</td><td>(<xref rid="bib46" ref-type="bibr">Liu et&#x000a0;al., 2010</xref>)</td></tr><tr><td><italic>Lumnitzera racemosa</italic></td><td>Stems and leaves</td><td>Emodin</td><td>(<xref rid="bib81" ref-type="bibr">Wu et&#x000a0;al., 2008</xref>)</td></tr><tr><td rowspan="2"><italic>Avicennia marina</italic></td><td>Leaves</td><td>Luteolin</td><td>(<xref rid="bib52" ref-type="bibr">Momtazi-borojeni et&#x000a0;al., 2013</xref>)</td></tr><tr><td>Aerial roots</td><td>Luteolin</td><td>(<xref rid="bib63" ref-type="bibr">Sharaf et&#x000a0;al., 2000</xref>)</td></tr><tr><td rowspan="2"><italic>Pongamia pinnata</italic></td><td>Stem</td><td>Luteolin</td><td>(<xref rid="bib42" ref-type="bibr">Li et&#x000a0;al., 2006</xref>)</td></tr><tr><td>Leaves</td><td>Luteolin</td><td>(<xref rid="bib3" ref-type="bibr">Ahmed et&#x000a0;al., 2010</xref>); (<xref rid="bib62" ref-type="bibr">Shamsuddin et&#x000a0;al., 2013</xref>)</td></tr></tbody></table></table-wrap></p></sec><sec id="sec3.2"><label>3.2</label><title>Spike protein</title><p id="p0090">The coronavirus (CoV) family has an abundance of similar spike proteins. This spike protein (S-protein) interacts with host cells, such as pulmonary and parabronchial epithelial cells, and aids in SARS-CoV-2 infection via the epithelial cell membrane (<xref rid="bib83" ref-type="bibr">Xia et&#x000a0;al., 2020</xref>). The surface spike (S) glycoprotein (S-protein) is an essential binding protein for fusion of the virus with the cell membrane of the target cells (host cells) via cellular receptor angiotensin-converting enzyme 2 (ACE-2) (<xref rid="bib67" ref-type="bibr">Song et&#x000a0;al., 2018</xref>). The S-protein has two main functions: the first is binding to the target cell (host cells), which can be imagined as a key in a lock (it must fit or match), and the second is fusion of the viral membrane with the host cell (human), which allows the virus to enter the target cell. Once in the target cell, the RNA from SARS-CoV-2 can be transferred into the host cell to immediately begin virus propagation (<xref rid="bib76" ref-type="bibr">Walls et&#x000a0;al., 2020</xref>), and then the virus will multiply (replicate) and be packaged into new viruses. The new copies of the virus will then leave the target cell and look for other target cells (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>) (<xref rid="bib60" ref-type="bibr">Risitano et&#x000a0;al., 2020</xref>). SARS-CoV-2 is easily transmitted because the S-protein on the virus surface binds quite efficiently to ACE-2 on human cells.<fig id="fig5"><label>Figure&#x000a0;5</label><caption><p>Mechanism of SARS CoV-2 entry and replication in target cells (adapted from <xref rid="bib60" ref-type="bibr">Risitano et&#x000a0;al., 2020</xref> with permission).</p></caption><alt-text id="alttext0030">Figure&#x000a0;5</alt-text><graphic xlink:href="gr5"/></fig></p><p id="p0095">As shown in a previous study of several potentially active compounds, the docking scores of cannabinoids, rhoifolin, pectolinarin, morin, kaempferol, epigallocatechin gallate, herbacetin, and hesperidin against the S-protein were &#x02013;10.2, &#x02013;9.5, &#x02013;9.8, &#x02013;8.8, &#x02013;8.5, &#x02013;9.8, &#x02013;8.3, and &#x02013;10.4, respectively (<xref rid="bib72" ref-type="bibr">Tallei et&#x000a0;al., 2020</xref>). Another investigation showed that hesperidin had a docking score against the S-protein of &#x02013;9.6 (<xref rid="bib75" ref-type="bibr">Utomo et&#x000a0;al., 2020</xref>). The docking scores of these natural compounds with the binding sites (protein) of the S-protein of SARS-CoV-2 are shown in <xref rid="tbl4" ref-type="table">Table&#x000a0;4</xref>.<table-wrap position="float" id="tbl4"><label>Table&#x000a0;4</label><caption><p>Docking scores of natural compounds towards the S-protein binding site in SARS-CoV-2.</p></caption><alt-text id="alttext0050">Table&#x000a0;4</alt-text><table frame="hsides" rules="groups"><thead><tr><th>Plant name</th><th>Family</th><th>Plant part used</th><th>Compound name</th><th>Binding energy</th><th>Binding site (protein)</th><th>Reference</th></tr></thead><tbody><tr><td>Marijuana (<italic>Cannabis</italic> spp.)</td><td>Cannabaceae</td><td>&#x02013;</td><td>Cannabinoids</td><td>&#x02013;10.2</td><td>S-protein (6VXX)</td><td><xref rid="bib72" ref-type="bibr">Tallei et&#x000a0;al. (2020)</xref></td></tr><tr><td>Rhus plant (<italic>Rhus succedanea</italic>), Bitter orange (<italic>Citrus aurantium</italic>), Bergamot (<italic>Citrus bergamia</italic>), Grapefruit (<italic>Citrus paradisi</italic>), Lemon (<italic>Citrus limon</italic>), Lablab beans (<italic>Lablab purpureus</italic>), Tomato (<italic>Lycopersicon esculentum</italic>), Artichoke (<italic>Cynara scolymus</italic>), Bananas (<italic>Musa</italic> spp.), Grape (<italic>Vitis vinifera</italic>)</td><td>&#x02013;</td><td>&#x02013;</td><td>Rhoifolin</td><td>&#x02013;9.5</td><td>S-protein (6VXX)</td><td><xref rid="bib72" ref-type="bibr">Tallei et&#x000a0;al. (2020)</xref></td></tr><tr><td>Plume thistles (<italic>Cirsium</italic> spp.), Yellow toadflax<break/>(<italic>Linaria vulgaris</italic>)</td><td>&#x02013;</td><td>&#x02013;</td><td>Pectolinarin</td><td>&#x02013;9.8</td><td>S protein (6VXX)</td><td><xref rid="bib72" ref-type="bibr">Tallei et&#x000a0;al. (2020)</xref></td></tr><tr><td>Osage orange (<italic>Maclura pomifera</italic>), Almond (<italic>Prunus dulcis</italic>), Old fustic (<italic>Chlorophora tinctoria</italic>), Guava (<italic>Psidium guajava</italic>)</td><td>&#x02013;</td><td>&#x02013;</td><td>Morin</td><td>&#x02013;8.8</td><td>S-protein (6VXX)</td><td><xref rid="bib72" ref-type="bibr">Tallei et&#x000a0;al. (2020)</xref></td></tr><tr><td>Kale (<italic>Brassica oleracea</italic> var. <italic>sabellica</italic>), Beans (<italic>Phaseolus vulgaris</italic>), Tea (<italic>Camellia sinensis</italic>), Spinach (<italic>Spinacia oleracea</italic>), Broccoli (<italic>Brassica oleracea</italic> var. <italic>Italica</italic>)</td><td>&#x02013;</td><td>&#x02013;</td><td>Kaempferol</td><td>&#x02013;8.5</td><td>S-protein (6VXX)</td><td><xref rid="bib72" ref-type="bibr">Tallei et&#x000a0;al. (2020)</xref></td></tr><tr><td>Tea (<italic>Camellia sinensis</italic>) (green tea), skin of Apple (<italic>Malus domestica</italic>), Plum (<italic>Prunus domestica</italic>), Onion (<italic>Allium cepa</italic>), Hazelnut (<italic>Corylus avellana</italic>)</td><td>&#x02013;</td><td>&#x02013;</td><td>Epigallocatechin gallate</td><td>&#x02013;9.8</td><td>S-protein (6VXX)</td><td><xref rid="bib72" ref-type="bibr">Tallei et&#x000a0;al. (2020)</xref></td></tr><tr><td>Golden root (<italic>Rhodiola</italic> spp.), Gossypium (<italic>Gossypium hirsutum</italic>), Common horsetail (<italic>Equisetum arvense</italic>), Common boneset (<italic>Eupatorium perfoliatum</italic>)</td><td>&#x02013;</td><td>&#x02013;</td><td>Herbacetin</td><td>&#x02013;8.3</td><td>S-protein (6VXX)</td><td><xref rid="bib72" ref-type="bibr">Tallei et&#x000a0;al. (2020)</xref></td></tr><tr><td>Citrus fruit (<italic>Citrus</italic> spp.), Peppermint (<italic>Mentha</italic> spp.), Yellow Toadflax (<italic>Linaria vulgaris</italic>)</td><td>&#x02013;</td><td>&#x02013;</td><td rowspan="2">Hesperidin</td><td>&#x02013;10.4</td><td>S-protein (6VXX)</td><td><xref rid="bib72" ref-type="bibr">Tallei et&#x000a0;al. (2020)</xref></td></tr><tr><td><italic>Citrus sp</italic>.</td><td>Rutaceae</td><td>&#x02013;</td><td>&#x02013;9.6</td><td>Spike glycoprotein-RBD (6LXT)</td><td><xref rid="bib75" ref-type="bibr">Utomo et&#x000a0;al. (2020)</xref></td></tr></tbody></table></table-wrap></p></sec></sec><sec id="sec4"><label>4</label><title>Targets for blocking RNA synthesis and viral replication</title><sec id="sec4.1"><label>4.1</label><title>3-chymotrypsin-like cysteine protease (3CL<sup>pro</sup>)</title><p id="p0100">3CL<sup>pro</sup> is a crucial enzyme for coronavirus replication (<xref rid="bib47" ref-type="bibr">Liu and Wang, 2020</xref>). 3CL<sup>pro</sup> mediates Nsps (nonstructural protein) maturation directly, which is significant in the virus life cycle. Investigations into the structure and catalytic mechanism of 3CL<sup>pro</sup> have made it an enticing target for anti-coronavirus drug development. Peptide and small molecular inhibitors primarily contain inhibitors of SARS-CoV-2 3CL<sup>pro</sup> (<xref rid="bib57" ref-type="bibr">Pillaiyar et&#x000a0;al., 2016</xref>).</p><p id="p0105">As presented in a previous study of several potentially active compounds, the best docking scores of cannabinoids, rhoifolin, pectolinarin, morin, kaempferol, epigallocatechin gallate, herbacetin, and hesperidin against 3CL<sup>pro</sup> were &#x02013;8, &#x02013;8.2, &#x02013;8.2, &#x02013;7.8, &#x02013;7.8, &#x02013;7.8, &#x02013;7.2, and &#x02013;8.3, respectively (<xref rid="bib72" ref-type="bibr">Tallei et&#x000a0;al., 2020</xref>).</p><p id="p0110">Hesperidin was found to dose-dependently inhibit the cleavage activity of the 3-C-like protease (3CL<sup>pro</sup>) of SARS coronavirus in cell-free and cell-based assays, with an IC<sub>50</sub> of 8.3 &#x003bc;M (<xref rid="bib45" ref-type="bibr">Lin et&#x000a0;al., 2005</xref>). A previous study also showed that the docked hesperidin compound against 3CL<sup>pro</sup> was &#x02013;13.51 (<xref rid="bib75" ref-type="bibr">Utomo et&#x000a0;al., 2020</xref>), and according to a previous investigation, the best hesperidin position against SARS-CoV-2 3CL<sup>pro</sup> had a score of &#x02013;10.1 (<xref rid="bib15" ref-type="bibr">Chen et&#x000a0;al., 2020a</xref>, <xref rid="bib16" ref-type="bibr">b</xref>).</p><p id="p0115">Another investigation reported that the rhoifolin binding score for SARS-CoV 3CL<sup>pro</sup> was &#x02013;9.565, and the induced-fit docking result of pectolinarin against SARS-CoV 3CL<sup>pro</sup> was &#x02013;8.054. Based on a previous description, the best binding positions against SARS-CoV 3CL<sup>pro</sup> of morin, kaempferol, and herbacetin had scores of &#x02013;8.930, &#x02013;8.526, and &#x02013;9.263, respectively (<xref rid="bib37" ref-type="bibr">Jo et&#x000a0;al., 2020</xref>). Epigallocatechin gallate has also been reported to prevent the proteolytic property of SARS-CoV 3CL<sup>pro</sup> (<xref rid="bib54" ref-type="bibr">Nguyen et&#x000a0;al., 2012</xref>). The docking scores of the binding sites of natural compounds towards 3CL<sup>pro</sup> of SARS-CoV-2 are presented in <xref rid="tbl5" ref-type="table">Table&#x000a0;5</xref>.<table-wrap position="float" id="tbl5"><label>Table&#x000a0;5</label><caption><p>Docking scores of the natural compounds towards the 3CL<sup>pro</sup> binding site of SARS-CoV-2.</p></caption><alt-text id="alttext0055">Table&#x000a0;5</alt-text><table frame="hsides" rules="groups"><thead><tr><th>Plant name</th><th>Family</th><th>Plant part used</th><th>Compound name</th><th>Binding energy</th><th>Binding site</th><th>Reference</th></tr></thead><tbody><tr><td>Marijuana (<italic>Cannabis</italic> spp.)</td><td>Cannabaceae</td><td/><td>Cannabinoids</td><td>&#x02013;8</td><td>&#x02013;</td><td><xref rid="bib72" ref-type="bibr">Tallei et&#x000a0;al. (2020)</xref></td></tr><tr><td>Rhus plant (<italic>Rhus succedanea</italic>), Bitter orange (<italic>Citrus aurantium</italic>), Bergamot (<italic>Citrus bergamia</italic>), Grapefruit (<italic>Citrus paradisi</italic>), Lemon (<italic>Citrus limon</italic>), Lablab beans (<italic>Lablab purpureus</italic>), Tomato (<italic>Lycopersicon esculentum</italic>), Artichoke (<italic>Cynara scolymus</italic>), Bananas (<italic>Musa</italic> spp.), Grape (<italic>Vitis vinifera</italic>)</td><td>&#x02013;</td><td>&#x02013;</td><td rowspan="2">Rhoifolin</td><td>&#x02013;8.2</td><td>&#x02013;</td><td><xref rid="bib72" ref-type="bibr">Tallei et&#x000a0;al. (2020)</xref></td></tr><tr><td/><td>&#x02013;</td><td>&#x02013;</td><td>&#x02013;9.565</td><td>Asp<sup>142</sup>, Gln<sup>166</sup>, Gln<sup>189</sup>, Leu<sup>167</sup>, Phe<sup>140</sup>, Thr<sup>24</sup>, Thr<sup>26</sup></td><td><xref rid="bib37" ref-type="bibr">Jo et&#x000a0;al. (2020)</xref></td></tr><tr><td>Plume thistles (<italic>Cirsium</italic> spp.), Yellow toadflax<break/>(<italic>Linaria vulgaris</italic>)</td><td>&#x02013;</td><td>&#x02013;</td><td rowspan="2">Pectolinarin</td><td>&#x02013;8.2</td><td>&#x02013;</td><td><xref rid="bib72" ref-type="bibr">Tallei et&#x000a0;al. (2020)</xref></td></tr><tr><td/><td>&#x02013;</td><td>&#x02013;</td><td>&#x02013;8.054</td><td>Gln<sup>189</sup>, Glu<sup>166</sup>, Gly<sup>143</sup>, HIE<sup>164</sup>, His<sup>41</sup>, His<sup>163</sup></td><td><xref rid="bib37" ref-type="bibr">Jo et&#x000a0;al. (2020)</xref></td></tr><tr><td>Osage orange (<italic>Maclura pomifera</italic>), Almond (<italic>Prunus dulcis</italic>), Old fustic (<italic>Chlorophora tinctoria</italic>), Guava (<italic>Psidium guajava</italic>)</td><td>&#x02013;</td><td>&#x02013;</td><td rowspan="2">Morin</td><td>&#x02013;7.8</td><td>&#x02013;</td><td><xref rid="bib72" ref-type="bibr">Tallei et&#x000a0;al. (2020)</xref></td></tr><tr><td/><td>&#x02013;</td><td>&#x02013;</td><td>&#x02013;8.930</td><td>Asp<sup>142</sup>, Ile<sup>188</sup>, Glu<sup>166</sup></td><td><xref rid="bib37" ref-type="bibr">Jo et&#x000a0;al. (2020)</xref></td></tr><tr><td>Kale (<italic>Brassica oleracea</italic> var. <italic>sabellica</italic>), Beans (<italic>Phaseolus vulgaris</italic>), Tea (<italic>Camellia sinensis</italic>), Spinach (<italic>Spinacia oleracea</italic>), Broccoli (<italic>Brassica oleracea</italic> var. <italic>Italica</italic>)</td><td>&#x02013;</td><td>&#x02013;</td><td rowspan="2">Kaempferol</td><td>&#x02013;7.8</td><td>&#x02013;</td><td><xref rid="bib72" ref-type="bibr">Tallei et&#x000a0;al. (2020)</xref></td></tr><tr><td/><td>&#x02013;</td><td>&#x02013;</td><td>&#x02013;8.526</td><td>Asp<sup>142</sup>, Ile<sup>188</sup>, Glu<sup>166</sup></td><td><xref rid="bib37" ref-type="bibr">Jo et&#x000a0;al. (2020)</xref></td></tr><tr><td>Tea (<italic>Camellia sinensis</italic>) (green tea), skin of Apple (<italic>Malus domestica</italic>), Plum (<italic>Prunus domestica</italic>), Onion (<italic>Allium cepa</italic>), Hazelnut (<italic>Corylus avellana</italic>)</td><td>&#x02013;</td><td>&#x02013;</td><td>Epigallocatechin gallate</td><td>&#x02013;7.8</td><td>&#x02013;</td><td><xref rid="bib72" ref-type="bibr">Tallei et&#x000a0;al. (2020)</xref></td></tr><tr><td>Golden root (<italic>Rhodiola</italic> spp.), Gossypium (<italic>Gossypium hirsutum</italic>), Common horsetail (<italic>Equisetum arvense</italic>), Common boneset (<italic>Eupatorium perfoliatum</italic>)</td><td>&#x02013;</td><td>&#x02013;</td><td>Herbacetin</td><td>&#x02013;7.2</td><td>&#x02013;</td><td><xref rid="bib72" ref-type="bibr">Tallei et&#x000a0;al. (2020)</xref></td></tr><tr><td/><td>&#x02013;</td><td>&#x02013;</td><td/><td>&#x02013;9.263</td><td>Asp<sup>142</sup>, Ile<sup>188</sup>, Gln<sup>189</sup>, Glu<sup>166</sup>, His<sup>41</sup></td><td><xref rid="bib37" ref-type="bibr">Jo et&#x000a0;al. (2020)</xref></td></tr><tr><td>Citrus fruit (<italic>Citrus</italic> spp.), Peppermint (<italic>Mentha</italic> spp.), Yellow Toadflax (<italic>Linaria vulgaris</italic>)</td><td>&#x02013;</td><td>&#x02013;</td><td rowspan="3">Hesperidin</td><td>&#x02013;8.3</td><td>&#x02013;</td><td><xref rid="bib72" ref-type="bibr">Tallei et&#x000a0;al. (2020)</xref></td></tr><tr><td><italic>Citrus sp</italic>.</td><td>Rutaceae</td><td>&#x02013;</td><td>&#x02013;13.51</td><td>&#x02013;</td><td><xref rid="bib75" ref-type="bibr">Utomo et&#x000a0;al. (2020)</xref></td></tr><tr><td/><td/><td/><td>&#x02013;10.1</td><td>&#x02013;</td><td><xref rid="bib15" ref-type="bibr">Chen et&#x000a0;al., 2020a</xref>, <xref rid="bib16" ref-type="bibr">b</xref></td></tr></tbody></table></table-wrap></p></sec><sec id="sec4.2"><label>4.2</label><title>Papain-like protease (PL<sup>pro</sup>)</title><p id="p0120">The polyproteins of the coronavirus are expressed after the papain-like protease (PL<sup>pro</sup>) enzyme plays a critical function in cleaving the polyproteins into fewer products, which are utilized for replicating novel viruses (<xref rid="bib79" ref-type="bibr">Wrapp et&#x000a0;al., 2020</xref>). PL<sup>pro</sup> controls the cleavage of the N-terminus of the replicase polyprotein to release Nsp1, Nsp2, and Nsp3, which is indispensable for modulating virus replication (<xref rid="bib27" ref-type="bibr">Harcourt et&#x000a0;al., 2004</xref>).</p><p id="p0125">The bioactive compounds from natural sources, including platycodin D, baicalin, sugetriol-3,9-diacetate (from <italic>Platycodon grandiflorus</italic>, <italic>Scutellaria baicalensis</italic>, <italic>Cyperus rotundus</italic>, respectively), phaitanthrin D and 2,2-di (3-indolyl)-3-indolent from <italic>Isatis indigotica</italic>, catechin compounds ((e)-epigallocatechin gallate and 2 (3,4-dihydroxy phenyl)-2-[[2-(3,4-dihydroxy phenyl)-3,4-dihydro5,7-dihydroxy-2H-1-benzopyran-3-yl]oxy]-3,4-dihydro-2H-1benzopyran-3,4,5,7-tetrol), exhibited strong binding affinity to PL<sup>pro</sup> protein, illustrating that these compounds could be used for SARS-CoV-2 therapeutics (<xref rid="bib80" ref-type="bibr">Wu et&#x000a0;al., 2020</xref>).</p><p id="p0130">Furthermore, the screening results reported in a previous study revealed that a series of drugs, including antivirals (ribavirin, valganciclovir, and thymidine), antibacterials (chloramphenicol, cefamandole, and tigecycline), muscle relaxants (chlorphenesin carbamate), and antitussives (levodropropizine), might all have a high binding affinity to PL<sup>pro</sup>. According to the docking model results, ribavirin attached to the active site of the enzyme and was described as a SARS-PL<sup>pro</sup> inhibitor (PDB code 3e9s). The interaction between ribavirin and the enzyme (hydrophobic interaction and strong hydrogen bonding) signifies that it is a potent PL<sup>pro</sup> inhibitor (<xref rid="bib80" ref-type="bibr">Wu et&#x000a0;al., 2020</xref>).</p></sec><sec id="sec4.3"><label>4.3</label><title>RNA-dependent RNA polymerase (RdRp)</title><p id="p0135">Coronavirus expresses RNA-dependent RNA polymerase (RdRp) to generate the daughter RNA genome, which is an a significant replication step that catalyzes the synthesis of complementary RNA strands utilizing viral RNA templates (<xref rid="bib53" ref-type="bibr">Mullard, 2018</xref>). The conserved protein in coronavirus (Nsp12) is an RdRp and the vital enzyme of the coronavirus replication or transcription complex (<xref rid="bib70" ref-type="bibr">Subissi et&#x000a0;al., 2014</xref>). According to a study on SARS-CoV and MERS-CoV inhibitors, Nsp12-RdRp has been shown to be a pivotal drug target. However, the targeted inhibition of Nsp12-RdRp might not induce significant toxicity and adverse impacts on host cells, and no particular inhibitors have been identified so far (<xref rid="bib17" ref-type="bibr">Chu et&#x000a0;al., 2006</xref>).</p><p id="p0140">Some bioactive compounds from natural sources and derivatives with antiviral, anti-inflammatory, and antitumor activities have revealed major binding affinity to RdRp, including betulonal, 2&#x003b2;,30&#x003b2;-dihydroxy-3,4-seco-friedelolactone-27-lactone, 14-deoxy-11,12-didehydroandrographolide, 1,7-dihydroxy-3-methoxyxanthone, and theaflavin 3,3&#x02032;-di-<italic>O</italic>-gallate (from <italic>Cassine xylocarpa</italic>, <italic>Andrographis paniculata</italic>, <italic>Swertia pseudochinensis</italic>, and <italic>Camellia sinensis</italic>, respectively); gnidicin and gniditrin (from <italic>Gnidia lamprantha</italic>); and andrographolide derivatives (<xref rid="bib80" ref-type="bibr">Wu et&#x000a0;al., 2020</xref>). It has been shown that RNA-dependent RNA polymerase was detected in a mangrove plant, <italic>Excoecaria agallocha</italic> (<xref rid="bib43" ref-type="bibr">Li et&#x000a0;al., 2012</xref>).</p></sec><sec id="sec4.4"><label>4.4</label><title>Helicase</title><p id="p0145">SARS-CoV-2 and other coronaviruses have an RNA helicase enzyme, which is important for viral replication and proliferation. A previous study demonstrated that myricetin and scutellarin compounds are capable of inhibiting helicase enzyme activity (<xref rid="bib87" ref-type="bibr">Yu et&#x000a0;al., 2012</xref>). Several Indonesian plants contain myricetin and scutellarin compounds; myricetin was found in clove plants (<italic>Syzygium aromaticum</italic>; flowers), duwet plants (<italic>Syzygium cumini</italic>; leaves), Semarang guava (<italic>Syzygium samarangense</italic>; leaves), and rosella (<italic>Hibiscus sabdariffa</italic>; flower petals), while scutellarin was found in Jakatuwa plants (<italic>Scoparia dulcis</italic>; leaves) and senggugu (<italic>Clerodendron serratum</italic>; leaves) (<xref rid="bib12" ref-type="bibr">Cai and Wu, 1996</xref>; <xref rid="bib40" ref-type="bibr">Kuo et&#x000a0;al., 2004</xref>; <xref rid="bib4" ref-type="bibr">Ali et&#x000a0;al., 2005</xref>; <xref rid="bib7" ref-type="bibr">Ayyanar and Subash-Babu, 2012</xref>; <xref rid="bib82" ref-type="bibr">Wu et&#x000a0;al., 2012</xref>; <xref rid="bib77" ref-type="bibr">Wang et&#x000a0;al., 2017</xref>).</p><p id="p0150">Some bioactive compounds from natural sources have revealed high binding affinity to helicase, including many flavanoids (a-glucosyl hesperidin, hesperidin, rutin, quercetagetin 6-O-bD-glucopyranoside, and homovitexin), xanthones such as 3,5-dimethoxy-1-[(6-O-bDxylopyranosyl-bD-glucopyranosyl)oxy]-9H-xanthen-9-one, kouitchenside H, kouitchenside A, 8,2-dihydroxy-3,4,5-trimethoxy-1 [(6-O-bD-xylopyranosyl-b-D-glucopyranosyl)oxy]-9H-xanthen-9one, kouitchenside D, 1-hydroxy-2,6-dimethoxy-8-[(6-O-bDxylopyranosyl-bD-glucopyranosyl)oxy]-9H-xanthen-9-one and triptexanthoside D from Swertia genus, phyllaemblicin B and phyllaemblinol from <italic>Phyllanthus emblica</italic> (<xref rid="bib80" ref-type="bibr">Wu et&#x000a0;al., 2020</xref>).</p><p id="p0155">In addition, according to structure-modeling helicase proteins, as described previously, several drugs, including antibacterial (lymecycline, cefsulodine, and rolitetracycline), antifungal (itraconazole), anti-HIV-1 (saquinavir), anticoagulant (dabigatran), and diuretic (canrenoic acid) drugs, have been projected through virtual ligand screening to be helicase inhibitors with high mfScores.</p></sec><sec id="sec4.5"><label>4.5</label><title>Serine protease</title><p id="p0160">As previously described, SARS-CoV-2 infection in humans not only requires ACE-2 receptors as an entry point but also involves the binding of the S-protein on the surface of the virus to ACE-2 receptors. At a later stage, the activity of the serine protease enzyme required by TMPRSS2 (a transmembrane glycol) allows for fusion and entry of the target cell to begin infection. The inhibition of serine protease activity is a target in the prevention of viral infections. Recently, it has been shown that in addition to inhibiting interactions with ACE-2 receptors, the inhibition of protease enzymes (especially serine proteases) is also an impending target for controlling SARS-CoV-2 infection. Compounds that inhibit proteases in serine residues (serine protease inhibitors, hereafter referred to as SPIs) are thought to be good candidate drugs to stop the viral life cycle. SARS-CoV-2 employs proteases to facilitate the infection of host cells, making proteases a significant therapeutic target, as they are involved in many vital processes in the propagation of coronaviruses (<xref rid="bib19" ref-type="bibr">Clemente et&#x000a0;al., 2019</xref>; <xref rid="bib32" ref-type="bibr">Hoffmann et&#x000a0;al., 2020</xref>).</p><p id="p0165">Plants are an abundant source of SPI and have been widely studied. SPI compounds derived from plants are generally in the form of proteins or molecules containing proteins (large molecules). Leguminous family plants (Fabaceae, Poaceae, and Solanaceae) are the primary sources of SPI-producing plants. The protein fraction derived from legumes is rich in SPI compounds. Examples of leguminous plants whose seeds contain SPI are peanuts (<italic>Arachis hypogaea</italic>), soybeans (<italic>Glycine max</italic>), beans (<italic>Phaseolus vulgaris</italic>), peas (<italic>Pisum sativum</italic>), and snore (<italic>Crotalaria juncea</italic>). In addition to legumes, several Indonesian plants contain SPI compounds, including moringa (<italic>Moringa oleifera</italic>; leaves and seeds), bitter melon (<italic>Momordica charantia</italic>; seeds), cucumber (<italic>Cucumis sativus</italic>; fruit), pumpkin (<italic>Cucurbita moschata</italic>; fruit), pineapple (<italic>Ananas comosus</italic>; fruit), sweet potato (<italic>Ipomoea batatas</italic>; tuber), and potato (<italic>Solanum tuberosum</italic>; tuber) (<xref rid="bib11" ref-type="bibr">Bijina et&#x000a0;al., 2011</xref>; <xref rid="bib68" ref-type="bibr">Srikanth and Chen, 2016</xref>). Furthermore, SPI has been reported in the mangrove plant <italic>Excoecaria agallocha</italic> (<xref rid="bib43" ref-type="bibr">Li et&#x000a0;al., 2012</xref>) and mangrove-associated <italic>Derris trifoliata</italic> (<xref rid="bib10" ref-type="bibr">Bhattacharyya and Babu, 2009</xref>).</p><p id="p0170">The Indonesian government encourages the potential use of domestic resources to deal with COVID-19. The efficacy claims of the products available to combat COVID-19 are more focused on the function of maintaining and increasing the human immune system (<xref rid="bib28" ref-type="bibr">Hartanti et&#x000a0;al., 2020</xref>). The future prospects of natural compounds on COVID-19 from Indonesian medicinal plants include, for example, trans-cinnamaldehyde and analogs of <italic>Cinnamomum verum</italic> as immunomodulators; 6-gingerol, 6-shogaol, and 8-shogaol of <italic>Zingiber officinale</italic> var. <italic>Rubrum</italic> as antioxidants (<xref rid="bib58" ref-type="bibr">Qadir et&#x000a0;al., 2018</xref>); curcumin and polysaccharide as immunomodulators; phyllanthin and the related phenolic compounds of <italic>Phyllanthus niruri</italic> as immunomodulators; and polysaccharides of <italic>Oryza sativa</italic> as immunomodulators (<xref rid="bib85" ref-type="bibr">Yang et&#x000a0;al., 2015</xref>).</p></sec></sec><sec id="sec5"><label>5</label><title>Conclusion</title><p id="p0175">In conclusion, all the compounds and plants mentioned in this review have not yet been tested for effectiveness in experimental models relevant to SARS-CoV-2 because this virus was only identified at the beginning of 2020. However, these plants possess the potential to prevent infection or inhibit the replication of SARS-CoV-2 based on the identified therapeutic targets in SARS-CoV-2 and their reaction to SARS-CoV.</p><p id="p0180">The results of the abovementioned computational model (<italic>in silico</italic>) predictions still need confirmation via laboratory testing and experimentation. Many strategies are being developed by researchers to seek out active antiviral compounds, including those derived from natural plant compounds. The rich biodiversity of Indonesian plants provides a variety of structural compounds from natural materials, providing major capital in the effort to identify suitable drug candidates to combat disease, including SARS-CoV-2. At the same time, this is a call for Indonesian researchers to support drug-independence programs.</p></sec><sec id="sec6"><title>Declarations</title><sec id="sec6.1"><title>Author contribution statement</title><p id="p0185">All authors listed have significantly contributed to the development and the writing of this article.</p></sec><sec id="sec6.2"><title>Funding statement</title><p id="p0190">This work was supported by the <funding-source id="gs1">Directorate General of Research and Community Service</funding-source>, the <funding-source id="gs2">Ministry of Research, and Technology</funding-source>/<funding-source id="gs3">National Agency for Research and Innovation</funding-source> of the Republic of Indonesia through <funding-source id="gs4">World-Class Research Program 2020</funding-source> (No. 214/SP2H/AMD/LT/DRPM/2020).</p></sec><sec sec-type="data-availability" id="sec6.3"><title>Data availability statement</title><p id="p0195">Data included in article/supplementary material/referenced in article.</p></sec><sec sec-type="COI-statement" id="sec6.4"><title>Declaration of interests statement</title><p id="p0200">The authors declare no conflict of interest.</p></sec><sec id="sec6.5"><title>Additional information</title><p id="p0205">No additional information is available for this paper.</p></sec></sec></body><back><ref-list id="cebib0010"><title>References</title><ref id="bib1"><element-citation publication-type="journal" id="sref1"><person-group person-group-type="author"><name><surname>Adedoyin</surname><given-names>T.A.</given-names></name><name><surname>Joshua</surname><given-names>I.O.</given-names></name><name><surname>Ofem</surname><given-names>O.E.</given-names></name><name><surname>Akpan</surname><given-names>J.</given-names></name></person-group><article-title>Effects of <italic>Cassia alata</italic> root extract on smooth muscle activity</article-title><source>J.&#x000a0;Pharmaceut. Res. Int.</source><year>2015</year><fpage>406</fpage><lpage>418</lpage></element-citation></ref><ref id="bib2"><element-citation publication-type="journal" id="sref2"><person-group person-group-type="author"><name><surname>Ahlawat</surname><given-names>K.S.</given-names></name><name><surname>Khatkar</surname><given-names>B.S.</given-names></name></person-group><article-title>Processing, food applications and safety of <italic>Aloe vera</italic> products: a review</article-title><source>J.&#x000a0;Food Sci. Technol.</source><volume>48</volume><issue>5</issue><year>2011</year><fpage>525</fpage><lpage>533</lpage><pub-id pub-id-type="pmid">23572784</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal" id="sref3"><person-group person-group-type="author"><name><surname>Ahmed</surname><given-names>F.</given-names></name><name><surname>Sadhu</surname><given-names>S.K.</given-names></name><name><surname>Ishibashi</surname><given-names>M.</given-names></name></person-group><article-title>Search for bioactive natural products from medicinal plants of Bangladesh</article-title><source>J.&#x000a0;Nat. Med.</source><volume>64</volume><issue>4</issue><year>2010</year><fpage>393</fpage><lpage>401</lpage><pub-id pub-id-type="pmid">20607429</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal" id="sref4"><person-group person-group-type="author"><name><surname>Ali</surname><given-names>B.H.</given-names></name><name><surname>Al Wabel</surname><given-names>N.</given-names></name><name><surname>Blunden</surname><given-names>G.</given-names></name></person-group><article-title>Phytochemical, pharmacological and toxicological aspects of <italic>Hibiscus sabdariffa</italic> L.: a review</article-title><source>Phytother Res.</source><volume>19</volume><issue>5</issue><year>2005</year><fpage>369</fpage><lpage>375</lpage><pub-id pub-id-type="pmid">16106391</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal" id="sref5"><person-group person-group-type="author"><name><surname>Alu'Datt</surname><given-names>M.H.</given-names></name><name><surname>Rababah</surname><given-names>T.</given-names></name><name><surname>Alhamad</surname><given-names>M.N.</given-names></name><name><surname>Al-Mahasneh</surname><given-names>M.A.</given-names></name><name><surname>Ereifej</surname><given-names>K.</given-names></name><name><surname>Al-Karaki</surname><given-names>G.</given-names></name></person-group><article-title>Profiles of free and bound phenolics extracted from Citrus fruits and their roles in biological systems: content, and antioxidant, anti-diabetic and anti-hypertensive properties</article-title><source>Food Funct.</source><volume>8</volume><issue>9</issue><year>2017</year><fpage>3187</fpage><lpage>3197</lpage><pub-id pub-id-type="pmid">28805834</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal" id="sref6"><person-group person-group-type="author"><name><surname>Amin</surname><given-names>M.S.</given-names></name><name><surname>Saputri</surname><given-names>F.C.</given-names></name><name><surname>Mun&#x02019;im</surname><given-names>A.</given-names></name></person-group><article-title>Inhibition of dipeptidyl peptidase 4 (DPP IV) activity by some Indonesia edible plants</article-title><source>Phcog. J.</source><volume>11</volume><issue>2</issue><year>2019</year><fpage>231</fpage><lpage>236</lpage></element-citation></ref><ref id="bib7"><element-citation publication-type="journal" id="sref7"><person-group person-group-type="author"><name><surname>Ayyanar</surname><given-names>M.</given-names></name><name><surname>Subash-Babu</surname><given-names>P.</given-names></name></person-group><article-title><italic>Syzygiumcumini</italic> (L.) Skeels: a review of its phytochemical constituents and traditional uses</article-title><source>Asian Pacific J. Trop. Biomed.</source><volume>2</volume><issue>3</issue><year>2012</year><fpage>240</fpage><lpage>246</lpage></element-citation></ref><ref id="bib8"><element-citation publication-type="journal" id="sref8"><person-group person-group-type="author"><name><surname>Azminah</surname><given-names>A.</given-names></name><name><surname>Erlina</surname><given-names>L.</given-names></name><name><surname>Radji</surname><given-names>M.</given-names></name><name><surname>Mun&#x02019;im</surname><given-names>A.</given-names></name><name><surname>Syahdi</surname><given-names>R.R.</given-names></name><name><surname>Yanuar</surname><given-names>A.</given-names></name></person-group><article-title>In silico and in vitro identification of candidate SIRT1 activators from Indonesian medicinal plants compounds database</article-title><source>Comput. Biol. Chem.</source><volume>83</volume><year>2019</year><fpage>107096</fpage><pub-id pub-id-type="pmid">31377446</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal" id="sref9"><person-group person-group-type="author"><name><surname>Belouzard</surname><given-names>S.</given-names></name><name><surname>Chu</surname><given-names>V.C.</given-names></name><name><surname>Whittaker</surname><given-names>G.R.</given-names></name></person-group><article-title>Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites</article-title><source>Proc. Natl. Acad. Sci. U.S.A.</source><volume>106</volume><year>2009</year><fpage>5871</fpage><lpage>5876</lpage><pub-id pub-id-type="pmid">19321428</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal" id="sref10"><person-group person-group-type="author"><name><surname>Bhattacharyya</surname><given-names>A.</given-names></name><name><surname>Babu</surname><given-names>C.R.</given-names></name></person-group><article-title>Purification and biochemical characterization of a serine proteinase inhibitor from <italic>Derris trifoliata</italic> Lour. seeds: insight into structural and antimalarial features</article-title><source>Phytochemistry</source><volume>70</volume><issue>6</issue><year>2009</year><fpage>703</fpage><lpage>712</lpage><pub-id pub-id-type="pmid">19409579</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal" id="sref11"><person-group person-group-type="author"><name><surname>Bijina</surname><given-names>B.</given-names></name><name><surname>Chellappan</surname><given-names>S.</given-names></name><name><surname>Krishna</surname><given-names>J.G.</given-names></name><name><surname>Basheer</surname><given-names>S.M.</given-names></name><name><surname>Elyas</surname><given-names>K.K.</given-names></name><name><surname>Bahkali</surname><given-names>A.H.</given-names></name><name><surname>Chandrasekaran</surname><given-names>M.</given-names></name></person-group><article-title>Protease inhibitor from <italic>Moringa oleifera</italic> with potential for use as therapeutic drug and as seafood preservative</article-title><source>Saudi J. Biol. Sci.</source><volume>18</volume><issue>3</issue><year>2011</year><fpage>273</fpage><lpage>281</lpage><pub-id pub-id-type="pmid">23961135</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal" id="sref12"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>L.</given-names></name><name><surname>Wu</surname><given-names>C.D.</given-names></name></person-group><article-title>Compounds from <italic>Syzygiumaromaticum</italic> possessing growth inhibitory activity against oral pathogens</article-title><source>J.&#x000a0;Nat. Prod.</source><volume>59</volume><issue>10</issue><year>1996</year><fpage>987</fpage><lpage>990</lpage><pub-id pub-id-type="pmid">8904847</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal" id="sref13"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>C.L.</given-names></name><name><surname>Shen</surname><given-names>C.C.</given-names></name><name><surname>Ni</surname><given-names>C.L.</given-names></name><name><surname>Chen</surname><given-names>C.C.</given-names></name></person-group><article-title>A&#x000a0;new sesquiterpene from <italic>Elephantopus scaber</italic></article-title><source>Hung Kuang J.</source><volume>65</volume><year>2011</year><fpage>49</fpage><lpage>56</lpage></element-citation></ref><ref id="bib14"><element-citation publication-type="book" id="sref14"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Du</surname><given-names>Q.</given-names></name></person-group><chapter-title>Potential Natural Compounds for Preventing SARS-CoV-2 (2019-nCoV) Infection</chapter-title><year>2020</year></element-citation></ref><ref id="bib15"><element-citation publication-type="journal" id="sref15"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>Q.</given-names></name><name><surname>Guo</surname><given-names>D.</given-names></name></person-group><article-title>Emerging coronaviruses: genome structure, replication, and pathogenesis</article-title><source>J.&#x000a0;Med. Virol.</source><volume>92</volume><year>2020</year><fpage>418</fpage><lpage>423</lpage><pub-id pub-id-type="pmid">31967327</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal" id="sref16"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y.W.</given-names></name><name><surname>Yiu</surname><given-names>C.P.B.</given-names></name><name><surname>Wong</surname><given-names>K.Y.</given-names></name></person-group><article-title>Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CLpro) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates</article-title><source>F1000 Res.</source><volume>9</volume><year>2020</year><fpage>129</fpage></element-citation></ref><ref id="bib17"><element-citation publication-type="journal" id="sref17"><person-group person-group-type="author"><name><surname>Chu</surname><given-names>C.K.</given-names></name><name><surname>Gadthula</surname><given-names>S.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Choo</surname><given-names>H.</given-names></name><name><surname>Olgen</surname><given-names>S.</given-names></name><name><surname>Barnard</surname><given-names>D.L.</given-names></name></person-group><article-title>Antiviral activity of nucleoside analogues against SARS-coronavirus (SARS-coV)</article-title><source>Antivir. Chem. Chemother.</source><volume>17</volume><year>2006</year><fpage>285e9</fpage><pub-id pub-id-type="pmid">17176633</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal" id="sref18"><person-group person-group-type="author"><name><surname>Chukwujekwu</surname><given-names>J.C.</given-names></name><name><surname>Coombes</surname><given-names>P.H.</given-names></name><name><surname>Mulholland</surname><given-names>D.A.</given-names></name><name><surname>Van Staden</surname><given-names>J.</given-names></name></person-group><article-title>Emodin, an antibacterial anthraquinone from the roots of <italic>Cassia occidentalis</italic></article-title><source>South Afr. J. Bot.</source><volume>72</volume><issue>2</issue><year>2006</year><fpage>295</fpage><lpage>297</lpage></element-citation></ref><ref id="bib19"><element-citation publication-type="journal" id="sref19"><person-group person-group-type="author"><name><surname>Clemente</surname><given-names>M.</given-names></name><name><surname>Corigliano</surname><given-names>M.G.</given-names></name><name><surname>Pariani</surname><given-names>S.A.</given-names></name><name><surname>S&#x000e1;nchez-L&#x000f3;pez</surname><given-names>E.F.</given-names></name><name><surname>Sander</surname><given-names>V.A.</given-names></name><name><surname>Ramos-Duarte</surname><given-names>V.A.</given-names></name></person-group><article-title>Plant serine protease inhibitors: biotechnology application in agriculture and molecular farming</article-title><source>Int. J. Mol. Sci.</source><volume>20</volume><issue>6</issue><year>2019</year><fpage>1345</fpage></element-citation></ref><ref id="bib20"><element-citation publication-type="journal" id="sref20"><person-group person-group-type="author"><name><surname>Das</surname><given-names>K.R.</given-names></name><name><surname>Iwasaki</surname><given-names>A.</given-names></name><name><surname>Suenaga</surname><given-names>K.</given-names></name><name><surname>Kato-Noguchi</surname><given-names>H.</given-names></name></person-group><article-title>Evaluation of phytotoxic potential and identification of phytotoxic substances in <italic>Cassia alata</italic> Linn. leaves</article-title><source>Acta Agric. Scand. Sect. B Soil Plant Sci</source><volume>69</volume><issue>6</issue><year>2019</year><fpage>479</fpage><lpage>488</lpage></element-citation></ref><ref id="bib21"><element-citation publication-type="journal" id="sref21"><person-group person-group-type="author"><name><surname>Elkhidir</surname><given-names>I.B.</given-names></name><name><surname>Yagi</surname><given-names>A.I.</given-names></name><name><surname>El Badawi</surname><given-names>S.M.</given-names></name><name><surname>Yagi</surname><given-names>S.M.</given-names></name></person-group><article-title>Toxicity of aqueous extract of <italic>Senna alexandrina</italic> miller pods on Newzealand rabbits</article-title><source>Eur. J. Med. Plants</source><year>2012</year><fpage>252</fpage><lpage>261</lpage></element-citation></ref><ref id="bib22"><element-citation publication-type="journal" id="sref22"><person-group person-group-type="author"><name><surname>Ge</surname><given-names>X.Y.</given-names></name><name><surname>Li</surname><given-names>J.L.</given-names></name><name><surname>Yang</surname><given-names>X.L.</given-names></name><name><surname>Chmura</surname><given-names>A.A.</given-names></name><name><surname>Zhu</surname><given-names>G.</given-names></name><name><surname>Epstein</surname><given-names>J.H.</given-names></name></person-group><article-title>Isolation and characterization of a bat SARS-like coronavirus that uses the ACE-2 receptor</article-title><source>Nature</source><volume>503</volume><year>2013</year><fpage>535</fpage><lpage>538</lpage><pub-id pub-id-type="pmid">24172901</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal" id="sref23"><person-group person-group-type="author"><name><surname>Gorbalenya</surname><given-names>A.E.</given-names></name><name><surname>Baker</surname><given-names>S.C.</given-names></name><name><surname>Baric</surname><given-names>R.S.</given-names></name><name><surname>de Groot</surname><given-names>R.J.</given-names></name><name><surname>Drosten</surname><given-names>C.</given-names></name><name><surname>Gulyaeva</surname><given-names>A.A.</given-names></name><name><surname>Haagmans</surname><given-names>B.L.</given-names></name><name><surname>Lauber</surname><given-names>C.</given-names></name><name><surname>Leontovich</surname><given-names>A.M.</given-names></name><name><surname>Neuman</surname><given-names>B.W.</given-names></name><name><surname>Penzar</surname><given-names>D.</given-names></name><name><surname>Perlman</surname><given-names>S.</given-names></name><name><surname>Poon</surname><given-names>L.L.M.</given-names></name><name><surname>Samborskiy</surname><given-names>D.V.</given-names></name><name><surname>Sidorov</surname><given-names>I.A.</given-names></name><name><surname>Sola</surname><given-names>I.</given-names></name><name><surname>Ziebuhr</surname><given-names>J.</given-names></name></person-group><article-title>The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2</article-title><source>Nat. Microbiol.</source><year>2020</year></element-citation></ref><ref id="bib24"><element-citation publication-type="journal" id="sref24"><person-group person-group-type="author"><name><surname>Guzik</surname><given-names>T.J.</given-names></name><name><surname>Mohiddin</surname><given-names>S.A.</given-names></name><name><surname>Dimarco</surname><given-names>A.</given-names></name><name><surname>Patel</surname><given-names>V.</given-names></name><name><surname>Savvatis</surname><given-names>K.</given-names></name><name><surname>Marelli-Berg</surname><given-names>F.M.</given-names></name><name><surname>Madhur</surname><given-names>M.S.</given-names></name><name><surname>Tomaszewski</surname><given-names>M.</given-names></name><name><surname>Maffia</surname><given-names>P.</given-names></name><name><surname>D'Acquisto</surname><given-names>F.</given-names></name><name><surname>Nicklin</surname><given-names>S.A.</given-names></name><name><surname>Marian</surname><given-names>A.J.</given-names></name><name><surname>Nosalski</surname><given-names>R.</given-names></name><name><surname>Murray</surname><given-names>E.C.</given-names></name><name><surname>Guzik</surname><given-names>B.</given-names></name><name><surname>Berry</surname><given-names>C.</given-names></name><name><surname>Touyz</surname><given-names>R.M.</given-names></name><name><surname>Kreutz</surname><given-names>R.</given-names></name><name><surname>Wang</surname><given-names>D.W.</given-names></name><name><surname>Bhella</surname><given-names>D.</given-names></name><name><surname>Sagliocco</surname><given-names>O.</given-names></name><name><surname>Crea</surname><given-names>F.</given-names></name><name><surname>Thomson</surname><given-names>E.C.</given-names></name><name><surname>McInnes</surname><given-names>I.B.</given-names></name></person-group><article-title>COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options</article-title><source>Cardiovasc. Res.</source><volume>116</volume><year>2020</year><fpage>1666</fpage><lpage>1687</lpage><pub-id pub-id-type="pmid">32352535</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal" id="sref25"><person-group person-group-type="author"><name><surname>Gyebi</surname><given-names>G.A.</given-names></name><name><surname>Ogunro</surname><given-names>O.B.</given-names></name><name><surname>Adegunloye</surname><given-names>A.P.</given-names></name><name><surname>Ogunyemi</surname><given-names>O.M.</given-names></name><name><surname>Afolabi</surname><given-names>S.O.</given-names></name></person-group><article-title>Potential inhibitors of coronavirus 3-chymotrypsin-like protease (3CL<sup>pro</sup>): an in silico screening of alkaloids and terpenoids from African medicinal plants</article-title><source>J.&#x000a0;Biomol. Struct. Dyn.</source><year>2020</year></element-citation></ref><ref id="bib26"><element-citation publication-type="journal" id="sref26"><person-group person-group-type="author"><name><surname>Han</surname><given-names>D.P.</given-names></name><name><surname>Penn-Nicholson</surname><given-names>A.</given-names></name><name><surname>Cho</surname><given-names>M.W.</given-names></name></person-group><article-title>Identification of critical determinants on ACE-2 for SARS-CoV entry and development of a potententry inhibitor</article-title><source>Virology</source><volume>350</volume><year>2006</year><fpage>15</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">16510163</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal" id="sref27"><person-group person-group-type="author"><name><surname>Harcourt</surname><given-names>B.H.</given-names></name><name><surname>Jukneliene</surname><given-names>D.</given-names></name><name><surname>Kanjanahaluethai</surname><given-names>A.</given-names></name><name><surname>Bechill</surname><given-names>J.</given-names></name><name><surname>Severson</surname><given-names>K.M.</given-names></name><name><surname>Smith</surname><given-names>C.M.</given-names></name></person-group><article-title>Identification of severe acute respiratory syndrome coronavirus replicase products and characterization of papain-like protease activity</article-title><source>J.&#x000a0;Virol.</source><volume>78</volume><year>2004</year><fpage>13600e12</fpage><pub-id pub-id-type="pmid">15564471</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal" id="sref28"><person-group person-group-type="author"><name><surname>Hartanti</surname><given-names>D.</given-names></name><name><surname>Dhiani</surname><given-names>B.A.</given-names></name><name><surname>Charisma</surname><given-names>S.L.</given-names></name><name><surname>Wahyuningrumet</surname><given-names>R.</given-names></name></person-group><article-title>The potential roles of jamu for COVID-19: a learn from the traditional Chinese medicine</article-title><source>Pharm. Sci. Res.</source><volume>7</volume><year>2020</year><fpage>12</fpage><lpage>22</lpage><comment>Special Issue on COVID-19</comment></element-citation></ref><ref id="bib29"><element-citation publication-type="journal" id="sref29"><person-group person-group-type="author"><name><surname>Haslberger</surname><given-names>A.</given-names></name><name><surname>Jacob</surname><given-names>U.</given-names></name><name><surname>Hippe</surname><given-names>B.</given-names></name><name><surname>Karlic</surname><given-names>H.</given-names></name></person-group><article-title>Mechanisms of selected functional foods against viral infections with a view on COVID-19: mini review</article-title><source>Funct. Foods Health Dis.</source><volume>10</volume><issue>5</issue><year>2020</year><fpage>195</fpage><lpage>209</lpage></element-citation></ref><ref id="bib30"><element-citation publication-type="journal" id="sref30"><person-group person-group-type="author"><name><surname>Hennebelle</surname><given-names>T.</given-names></name><name><surname>Weniger</surname><given-names>B.</given-names></name><name><surname>Joseph</surname><given-names>H.</given-names></name><name><surname>Sahpaz</surname><given-names>S.</given-names></name><name><surname>Bailleul</surname><given-names>F.</given-names></name></person-group><article-title>Senna alata</article-title><source>Fitoterapia</source><volume>80</volume><issue>7</issue><year>2009</year><fpage>385</fpage><lpage>393</lpage><pub-id pub-id-type="pmid">19446609</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal" id="sref31"><person-group person-group-type="author"><name><surname>Ho</surname><given-names>T.Y.</given-names></name><name><surname>Wu</surname><given-names>S.L.</given-names></name><name><surname>Chen</surname><given-names>J.C.</given-names></name><name><surname>Li</surname><given-names>C.C.</given-names></name><name><surname>Hsiang</surname><given-names>C.Y.</given-names></name></person-group><article-title>Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction</article-title><source>Antivir. Res.</source><volume>74</volume><issue>2</issue><year>2007</year><fpage>92</fpage><lpage>101</lpage><pub-id pub-id-type="pmid">16730806</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal" id="sref32"><person-group person-group-type="author"><name><surname>Hoffmann</surname><given-names>M.</given-names></name><name><surname>Kleine-Weber</surname><given-names>H.</given-names></name><name><surname>Schroeder</surname><given-names>S.</given-names></name><name><surname>Kr&#x000fc;ger</surname><given-names>N.</given-names></name><name><surname>Herrler</surname><given-names>T.</given-names></name><name><surname>Erichsen</surname><given-names>S.</given-names></name></person-group><article-title>SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor</article-title><source>Cell</source><year>2020</year></element-citation></ref><ref id="bib33"><element-citation publication-type="journal" id="sref33"><person-group person-group-type="author"><name><surname>Hsu</surname><given-names>S.C.</given-names></name><name><surname>Chung</surname><given-names>J.G.</given-names></name></person-group><article-title>Anticancer potential of emodin</article-title><source>Biomedicine</source><volume>2</volume><issue>3</issue><year>2012</year><fpage>108</fpage><lpage>116</lpage><pub-id pub-id-type="pmid">32289000</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal" id="sref34"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Ren</surname><given-names>L.</given-names></name><name><surname>Zhao</surname><given-names>J.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Fan</surname><given-names>G.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Gu</surname><given-names>X.</given-names></name><name><surname>Cheng</surname><given-names>Z.</given-names></name><name><surname>Yu</surname><given-names>T.</given-names></name><name><surname>Xia</surname><given-names>J.</given-names></name><name><surname>Wei</surname><given-names>Y.</given-names></name><name><surname>Wu</surname><given-names>W.</given-names></name><name><surname>Xie</surname><given-names>X.</given-names></name><name><surname>Yin</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Liu</surname><given-names>M.</given-names></name><name><surname>Cao</surname><given-names>B.</given-names></name></person-group><article-title>Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China</article-title><source>Lancet</source><volume>395</volume><issue>10223</issue><year>2020</year><fpage>497</fpage><lpage>506</lpage><pub-id pub-id-type="pmid">31986264</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal" id="sref35"><person-group person-group-type="author"><name><surname>Ibrahim</surname><given-names>F.</given-names></name><name><surname>Natasha</surname><given-names>A.</given-names></name><name><surname>Saharman</surname><given-names>Y.R.</given-names></name><name><surname>Sudarmono</surname><given-names>P.</given-names></name></person-group><article-title>Preliminary report of COVID 19 testing: experience on clinical microbiology laboratory Universitas Indonesia in jakarta, Indonesia</article-title><source>New Microb. New Infect.</source><year>2020</year></element-citation></ref><ref id="bib36"><element-citation publication-type="journal" id="sref36"><person-group person-group-type="author"><name><surname>Jia</surname><given-names>H.P.</given-names></name><name><surname>Look</surname><given-names>D.C.</given-names></name><name><surname>Shi</surname><given-names>L.</given-names></name><name><surname>Hickey</surname><given-names>M.</given-names></name><name><surname>Pewe</surname><given-names>L.</given-names></name><name><surname>Netland</surname><given-names>J.</given-names></name></person-group><article-title>ACE-2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on dierentiation of human airway epithelia</article-title><source>J.&#x000a0;Virol.</source><volume>79</volume><issue>23</issue><year>2005</year><fpage>14614</fpage><lpage>14621</lpage><pub-id pub-id-type="pmid">16282461</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal" id="sref37"><person-group person-group-type="author"><name><surname>Jo</surname><given-names>S.</given-names></name><name><surname>Kim</surname><given-names>S.</given-names></name><name><surname>Shin</surname><given-names>D.H.</given-names></name><name><surname>Kim</surname><given-names>M.S.</given-names></name></person-group><article-title>Inhibition of SARS-CoV 3CL protease by flavonoids</article-title><source>J.&#x000a0;Enzym. Inhib. Med. Chem.</source><volume>35</volume><issue>1</issue><year>2020</year><fpage>145</fpage><lpage>151</lpage></element-citation></ref><ref id="bib38"><element-citation publication-type="book" id="sref38"><person-group person-group-type="author"><name><surname>Kuhn</surname><given-names>J.H.</given-names></name><name><surname>Radoshitzky</surname><given-names>S.R.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Wong</surname><given-names>S.K.</given-names></name><name><surname>Choe</surname><given-names>H.</given-names></name><name><surname>Farzan</surname><given-names>M.</given-names></name></person-group><chapter-title>The SARS Coronavirus Receptor ACE-2 A Potential Target for Antiviral Therapy</chapter-title><source>New Concepts of Antiviral Therapy</source><year>2006</year><publisher-name>Springer</publisher-name><fpage>397</fpage><lpage>418</lpage></element-citation></ref><ref id="bib39"><element-citation publication-type="journal" id="sref39"><person-group person-group-type="author"><name><surname>Kuo</surname><given-names>I.P.</given-names></name><name><surname>Lee</surname><given-names>P.T.</given-names></name><name><surname>Nan</surname><given-names>F.H.</given-names></name></person-group><article-title>Rheum officinale extract promotes the innate immunity of orange-spotted grouper (<italic>Epinephelus coioides</italic>) and exerts strong bactericidal activity against six aquatic pathogens</article-title><source>Fish Shellfish Immunol.</source><volume>102</volume><year>2020</year><fpage>117</fpage><lpage>124</lpage><pub-id pub-id-type="pmid">32305503</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal" id="sref40"><person-group person-group-type="author"><name><surname>Kuo</surname><given-names>Y.C.</given-names></name><name><surname>Yang</surname><given-names>L.M.</given-names></name><name><surname>Lin</surname><given-names>L.C.</given-names></name></person-group><article-title>Isolation and immunomodulatory effect of avonoids from <italic>Syzygium samarangense</italic></article-title><source>Planta Med.</source><volume>70</volume><issue>12</issue><year>2004</year><fpage>1237</fpage><lpage>1239</lpage><pub-id pub-id-type="pmid">15643565</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal" id="sref41"><person-group person-group-type="author"><name><surname>Letko</surname><given-names>M.</given-names></name><name><surname>Marzi</surname><given-names>A.</given-names></name><name><surname>Munster</surname><given-names>V.</given-names></name></person-group><article-title>Functional assessment of cell entry and receptor usage for lineage B &#x003b2;-coronaviruses, including 2019-nCoV</article-title><source>Nat. Microbiol.</source><volume>5</volume><year>2020</year><fpage>562</fpage><lpage>569</lpage><pub-id pub-id-type="pmid">32094589</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal" id="sref42"><person-group person-group-type="author"><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Shi</surname><given-names>C.</given-names></name><name><surname>Deng</surname><given-names>Z.</given-names></name><name><surname>Fu</surname><given-names>H.</given-names></name><name><surname>Proksch</surname><given-names>P.</given-names></name></person-group><article-title>Pongamone A&#x02013;E, five flavonoids from the stems of a mangrove plant, <italic>Pongamia pinnata</italic></article-title><source>Phytochemistry</source><volume>67</volume><issue>13</issue><year>2006</year><fpage>1347</fpage><lpage>1352</lpage><pub-id pub-id-type="pmid">16814820</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal" id="sref43"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Yu</surname><given-names>S.</given-names></name><name><surname>Liu</surname><given-names>D.</given-names></name><name><surname>Proksch</surname><given-names>P.</given-names></name><name><surname>Lin</surname><given-names>W.</given-names></name></person-group><article-title>Inhibitory effects of polyphenols toward HCV from the mangrove plant <italic>Excoecaria agallocha</italic> L</article-title><source>Bioorg. Med. Chem. Lett</source><volume>22</volume><issue>2</issue><year>2012</year><fpage>1099</fpage><lpage>1102</lpage><pub-id pub-id-type="pmid">22196120</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal" id="sref44"><person-group person-group-type="author"><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Moore</surname><given-names>M.J.</given-names></name><name><surname>Vasilieva</surname><given-names>N.</given-names></name><name><surname>Sui</surname><given-names>J.</given-names></name><name><surname>Wong</surname><given-names>S.K.</given-names></name><name><surname>Berne</surname><given-names>M.A.</given-names></name></person-group><article-title>Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus</article-title><source>Nature</source><volume>426</volume><year>2003</year><fpage>450</fpage><lpage>454</lpage><pub-id pub-id-type="pmid">14647384</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal" id="sref45"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>C.W.</given-names></name><name><surname>Tsai</surname><given-names>F.J.</given-names></name><name><surname>Tsai</surname><given-names>C.H.</given-names></name><name><surname>Lai</surname><given-names>C.C.</given-names></name><name><surname>Wan</surname><given-names>L.</given-names></name><name><surname>Ho</surname><given-names>T.Y.</given-names></name></person-group><article-title>Anti-SARS coronavirus 3C-like protease effects of <italic>Isatis indigotica</italic> root and plant-derived phenolic compounds</article-title><source>Antivir. Res.</source><volume>68</volume><issue>1</issue><year>2005</year><fpage>36</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">16115693</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal" id="sref46"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>F.</given-names></name><name><surname>Cai</surname><given-names>X.L.</given-names></name><name><surname>Yang</surname><given-names>H.</given-names></name><name><surname>Xia</surname><given-names>X.K.</given-names></name><name><surname>Guo</surname><given-names>Z.Y.</given-names></name><name><surname>Yuan</surname><given-names>J.</given-names></name></person-group><article-title>The bioactive metabolites of the mangrove endophytic fungus Talaromyces sp. ZH-154 isolated from <italic>Kandelia candel</italic> (L.) Druce</article-title><source>Planta Med.</source><volume>76</volume><issue>2</issue><year>2010</year><fpage>185</fpage><lpage>189</lpage><pub-id pub-id-type="pmid">19670161</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="book" id="sref47"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>X.J.</given-names></name></person-group><chapter-title>Potential Inhibitors for 2019-nCoV Coronavirus M Protease from Clinically Approved Medicines</chapter-title><year>2020</year></element-citation></ref><ref id="bib48"><element-citation publication-type="journal" id="sref48"><person-group person-group-type="author"><name><surname>Mageney</surname><given-names>V.</given-names></name><name><surname>Neugart</surname><given-names>S.</given-names></name><name><surname>Albach</surname><given-names>D.C.</given-names></name></person-group><article-title>A&#x000a0;guide to the variability of flavonoids in <italic>Brassica oleracea</italic></article-title><source>Molecules</source><volume>22</volume><issue>2</issue><year>2017</year><fpage>252</fpage></element-citation></ref><ref id="bib49"><element-citation publication-type="journal" id="sref49"><person-group person-group-type="author"><name><surname>Masters</surname><given-names>P.S.</given-names></name></person-group><article-title>The molecular biology of coronaviruses</article-title><source>Adv. Virus Res.</source><volume>66</volume><year>2006</year><fpage>193</fpage><lpage>292</lpage><pub-id pub-id-type="pmid">16877062</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal" id="sref50"><person-group person-group-type="author"><name><surname>Materska</surname><given-names>M.</given-names></name><name><surname>Konopacka</surname><given-names>M.</given-names></name><name><surname>Rogoli&#x00144;ski</surname><given-names>J.</given-names></name><name><surname>&#x0015a;losarek</surname><given-names>K.</given-names></name></person-group><article-title>Antioxidant activity and protective effects against oxidative damage of human cells induced by x-radiation of phenolic glycosides isolated from pepper fruits <italic>Capsicum annuum</italic> L</article-title><source>J.&#x000a0;Food Chem.</source><volume>168</volume><issue>1</issue><year>2015</year><fpage>546</fpage><lpage>553</lpage></element-citation></ref><ref id="bib51"><element-citation publication-type="journal" id="sref51"><person-group person-group-type="author"><name><surname>Miean</surname><given-names>K.H.</given-names></name><name><surname>Mohamed</surname><given-names>S.</given-names></name></person-group><article-title>Flavonoid (myricetin, quercetin, kaempferol, luteolin, and apigenin) content of edible tropical plants</article-title><source>J.&#x000a0;Agric. Food Chem.</source><volume>49</volume><issue>6</issue><year>2001</year><fpage>3106</fpage><lpage>3112</lpage><pub-id pub-id-type="pmid">11410016</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal" id="sref52"><person-group person-group-type="author"><name><surname>Momtazi-borojeni</surname><given-names>A.A.</given-names></name><name><surname>Behbahani</surname><given-names>M.</given-names></name><name><surname>Sadeghi-aliabadi</surname><given-names>H.</given-names></name></person-group><article-title>Antiproliferative activity and apoptosis induction of crude extract and fractions of <italic>Avicennia marina</italic></article-title><source>Iran. J. Basic Med. Sci.</source><volume>16</volume><issue>11</issue><year>2013</year><fpage>1203</fpage><pub-id pub-id-type="pmid">24494074</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal" id="sref53"><person-group person-group-type="author"><name><surname>Mullard</surname><given-names>A.</given-names></name></person-group><article-title>Ebola outbreak prompts experimental drug rollout</article-title><source>Nat. Rev. Drug Discov.</source><volume>17</volume><year>2018</year><fpage>460</fpage></element-citation></ref><ref id="bib54"><element-citation publication-type="journal" id="sref54"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>T.T.H.</given-names></name><name><surname>Woo</surname><given-names>H.J.</given-names></name><name><surname>Kang</surname><given-names>H.K.</given-names></name><name><surname>Nguyen</surname><given-names>V.D.</given-names></name><name><surname>Kim</surname><given-names>Y.M.</given-names></name><name><surname>Kim</surname><given-names>D.W.</given-names></name></person-group><article-title>Flavonoid-mediated inhibition of SARS coronavirus 3C-like protease expressed in <italic>Pichia pastoris</italic></article-title><source>Biotechnol. Lett.</source><volume>34</volume><year>2012</year><fpage>831</fpage><lpage>838</lpage><pub-id pub-id-type="pmid">22350287</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="book" id="sref55"><person-group person-group-type="author"><name><surname>Noor</surname><given-names>Y.R.</given-names></name><name><surname>Khazali</surname><given-names>M.</given-names></name><name><surname>Suryadiputra</surname><given-names>I.N.N.</given-names></name></person-group><chapter-title>Panduanpengenalan mangrove di Indonesia</chapter-title><year>1999</year><publisher-name>PKA/WI-IP (Wetlands International-Indonesia Programme)</publisher-name><publisher-loc>Bogor</publisher-loc><fpage>220</fpage></element-citation></ref><ref id="bib56"><element-citation publication-type="journal" id="sref56"><person-group person-group-type="author"><name><surname>Omrani</surname><given-names>A.S.</given-names></name><name><surname>Saad</surname><given-names>M.M.</given-names></name><name><surname>Baig</surname><given-names>K.</given-names></name><name><surname>Bahloul</surname><given-names>A.</given-names></name><name><surname>Abdul-Matin</surname><given-names>M.</given-names></name><name><surname>Alaidaroos</surname><given-names>A.Y.</given-names></name></person-group><article-title>Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study</article-title><source>Lancet Infect. Dis.</source><volume>14</volume><year>2014</year><fpage>1090</fpage><lpage>1095</lpage><pub-id pub-id-type="pmid">25278221</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal" id="sref57"><person-group person-group-type="author"><name><surname>Pillaiyar</surname><given-names>T.</given-names></name><name><surname>Manickam</surname><given-names>M.</given-names></name><name><surname>Namasivayam</surname><given-names>V.</given-names></name><name><surname>Hayashi</surname><given-names>Y.</given-names></name><name><surname>Jung</surname><given-names>S.H.</given-names></name></person-group><article-title>An overview of severe acute respiratory syndrome-coronavirus (SARS-CoV) 3CL protease inhibitors: peptidomimetics and small molecule chemotherapy</article-title><source>J.&#x000a0;Med. Chem.</source><volume>59</volume><year>2016</year><fpage>6595</fpage><lpage>6628</lpage><pub-id pub-id-type="pmid">26878082</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal" id="sref58"><person-group person-group-type="author"><name><surname>Qadir</surname><given-names>M.M.F.</given-names></name><name><surname>Bhatti</surname><given-names>A.</given-names></name><name><surname>Ashraf</surname><given-names>M.U.</given-names></name><name><surname>Sandhu</surname><given-names>M.A.</given-names></name><name><surname>Anjum</surname><given-names>S.</given-names></name><name><surname>John</surname><given-names>P.</given-names></name></person-group><article-title>Immunomodulatory and therapeutic role of <italic>Cinnamomum verum</italic> extracts in collagen-induced arthritic BALB/c mice</article-title><source>Immunopharmacology</source><volume>26</volume><issue>1</issue><year>2018</year><fpage>157</fpage><lpage>170</lpage></element-citation></ref><ref id="bib59"><element-citation publication-type="journal" id="sref59"><person-group person-group-type="author"><name><surname>Ramsay</surname><given-names>A.</given-names></name><name><surname>Mueller-Harvey</surname><given-names>I.</given-names></name></person-group><article-title>Procyanidins from <italic>Averrhoa bilimbi</italic> fruits and leaves</article-title><source>J.&#x000a0;Food Compos. Anal.</source><volume>47</volume><year>2016</year><fpage>16</fpage><lpage>20</lpage></element-citation></ref><ref id="bib60"><element-citation publication-type="journal" id="sref60"><person-group person-group-type="author"><name><surname>Risitano</surname><given-names>A.M.</given-names></name><name><surname>Mastellos</surname><given-names>D.C.</given-names></name><name><surname>Huber-Lang</surname><given-names>M.</given-names></name><name><surname>Yancopoulou</surname><given-names>D.</given-names></name><name><surname>Garlanda</surname><given-names>C.</given-names></name><name><surname>Ciceri</surname><given-names>F.</given-names></name><name><surname>Lambris</surname><given-names>J.D.</given-names></name></person-group><article-title>Complement as a target in COVID-19?</article-title><source>Nat. Rev. Immunol.</source><year>2020</year></element-citation></ref><ref id="bib61"><element-citation publication-type="journal" id="sref61"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>S.</given-names></name><name><surname>Zietz</surname><given-names>M.</given-names></name><name><surname>Schreiner</surname><given-names>M.</given-names></name><name><surname>Rohn</surname><given-names>S.</given-names></name><name><surname>Kroh</surname><given-names>L.W.</given-names></name><name><surname>Krumbein</surname><given-names>A.</given-names></name></person-group><article-title>Genotypic and climatic influences on the concentration and composition of flavonoids in kale (<italic>Brassica oleracea</italic> var. sabellica)</article-title><source>Food Chem.</source><volume>119</volume><issue>4</issue><year>2010</year><fpage>1293</fpage><lpage>1299</lpage></element-citation></ref><ref id="bib62"><element-citation publication-type="journal" id="sref62"><person-group person-group-type="author"><name><surname>Shamsuddin</surname><given-names>A.A.</given-names></name><name><surname>Najiah</surname><given-names>M.</given-names></name><name><surname>Suvik</surname><given-names>A.</given-names></name><name><surname>Azariyah</surname><given-names>M.N.</given-names></name><name><surname>Kamaruzzaman</surname><given-names>B.Y.</given-names></name><name><surname>Effendy</surname><given-names>A.W.</given-names></name></person-group><article-title>Antibacterial properties of selected mangrove plants against Vibrio species and its cytotoxicity against <italic>Artemia salina</italic></article-title><source>World Appl. Sci. J.</source><volume>25</volume><issue>2</issue><year>2013</year><fpage>333</fpage><lpage>340</lpage></element-citation></ref><ref id="bib63"><element-citation publication-type="journal" id="sref63"><person-group person-group-type="author"><name><surname>Sharaf</surname><given-names>M.</given-names></name><name><surname>El-Ansari</surname><given-names>M.A.</given-names></name><name><surname>Saleh</surname><given-names>N.A.M.</given-names></name></person-group><article-title>New flavonoids from <italic>Avicennia marina</italic></article-title><source>Fitoterapia</source><volume>71</volume><issue>3</issue><year>2000</year><fpage>274</fpage><lpage>277</lpage><pub-id pub-id-type="pmid">10844167</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal" id="sref64"><person-group person-group-type="author"><name><surname>Shivashri</surname><given-names>C.</given-names></name><name><surname>Rajarajeshwari</surname><given-names>T.</given-names></name><name><surname>Rajasekar</surname><given-names>P.</given-names></name></person-group><article-title>Hepatoprotective action of celery (<italic>Apium graveolens</italic>) leaves in acetaminophen-fed freshwater fish (<italic>Pangasius sutchi</italic>)</article-title><source>Fish Physiol. Biochem.</source><volume>39</volume><issue>5</issue><year>2013</year><fpage>1057</fpage><lpage>1069</lpage><pub-id pub-id-type="pmid">23288624</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal" id="sref65"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>B.</given-names></name><name><surname>Singh</surname><given-names>J.P.</given-names></name><name><surname>Kaur</surname><given-names>A.</given-names></name><name><surname>Singh</surname><given-names>N.</given-names></name></person-group><article-title>Phenolic composition, antioxidant potential and health benefits of citrus peel</article-title><source>Food Res. Int.</source><year>2020</year><fpage>109114</fpage><pub-id pub-id-type="pmid">32331689</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal" id="sref66"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>T.</given-names></name><name><surname>Goel</surname><given-names>R.K.</given-names></name></person-group><article-title>Neuroprotective effect of <italic>Allium cepa</italic> L. in aluminium chloride induced neurotoxicity</article-title><source>Neurotoxicology</source><volume>49</volume><year>2015</year><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">25940660</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal" id="sref67"><person-group person-group-type="author"><name><surname>Song</surname><given-names>W.</given-names></name><name><surname>Gui</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Xiang</surname><given-names>Y.</given-names></name></person-group><article-title>Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2</article-title><source>PLoS Pathog.</source><volume>14</volume><issue>8</issue><year>2018</year><object-id pub-id-type="publisher-id">e1007236</object-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal" id="sref68"><person-group person-group-type="author"><name><surname>Srikanth</surname><given-names>S.</given-names></name><name><surname>Chen</surname><given-names>Z.</given-names></name></person-group><article-title>Plant protease inhibitors in therapeutics-focus on cancer therapy</article-title><source>Front. Pharmacol.</source><volume>7</volume><year>2016</year><fpage>470</fpage><comment>470</comment><pub-id pub-id-type="pmid">28008315</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal" id="sref69"><person-group person-group-type="author"><name><surname>Su</surname><given-names>M.</given-names></name><name><surname>Wu</surname><given-names>X.</given-names></name><name><surname>Chung</surname><given-names>H.Y.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Ye</surname><given-names>W.</given-names></name></person-group><article-title>Antiproliferative activities of five Chinese medicinal herbs and active compounds in <italic>Elephantopus scaber</italic></article-title><source>Nat. Prod. Commun.</source><volume>4</volume><issue>8</issue><year>2009</year><fpage>1025</fpage><lpage>1030</lpage><pub-id pub-id-type="pmid">19768977</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal" id="sref70"><person-group person-group-type="author"><name><surname>Subissi</surname><given-names>L.</given-names></name><name><surname>Imbert</surname><given-names>I.</given-names></name><name><surname>Ferron</surname><given-names>F.</given-names></name><name><surname>Collet</surname><given-names>A.</given-names></name><name><surname>Coutard</surname><given-names>B.</given-names></name><name><surname>Decroly</surname><given-names>E.</given-names></name></person-group><article-title>SARS-CoV ORF1b-encoded nonstructural proteins 12e16: replicative enzymes as antiviral targets</article-title><source>Antivir. Res.</source><volume>101</volume><year>2014</year><object-id pub-id-type="publisher-id">122e30</object-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal" id="sref71"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>S.</given-names></name><name><surname>Yoshiya</surname><given-names>T.</given-names></name><name><surname>Yoshizawa-Kumagaye</surname><given-names>K.</given-names></name><name><surname>Sugiyama</surname><given-names>T.</given-names></name></person-group><article-title>Nicotianamine is a novel angiotensin-converting enzyme 2 inhibitor in soybean</article-title><source>Biomed. Res.</source><volume>36</volume><issue>3</issue><year>2015</year><fpage>219</fpage><lpage>224</lpage><pub-id pub-id-type="pmid">26106051</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="book" id="sref72"><person-group person-group-type="author"><name><surname>Tallei</surname><given-names>T.E.</given-names></name><name><surname>Tumilaar</surname><given-names>S.G.</given-names></name><name><surname>Niode</surname><given-names>N.J.</given-names></name><name><surname>Fatimawali</surname></name><name><surname>Kepel</surname><given-names>B.J.</given-names></name><name><surname>Idroes</surname><given-names>R.</given-names></name></person-group><chapter-title>Potential of Plant Bioactive Compounds as SARS-CoV-2 Main Protease (M) and Spike (S) Glycoprotein Inhibitors: a Molecular Docking Study</chapter-title><year>2020</year></element-citation></ref><ref id="bib73"><element-citation publication-type="journal" id="sref73"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>X.</given-names></name><name><surname>Xu</surname><given-names>C.</given-names></name><name><surname>Yagiz</surname><given-names>Y.</given-names></name><name><surname>Simonne</surname><given-names>A.</given-names></name><name><surname>Marshall</surname><given-names>M.R.</given-names></name></person-group><article-title>Phytochemical profiles, and antimicrobial and antioxidant activities of greater galangal [<italic>Alpinia galanga</italic> (Linn.) Swartz.] flowers</article-title><source>Food Chem.</source><volume>255</volume><year>2018</year><fpage>300</fpage><lpage>308</lpage><pub-id pub-id-type="pmid">29571480</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal" id="sref74"><person-group person-group-type="author"><name><surname>Teuwen</surname><given-names>L.A.</given-names></name><name><surname>Geldhof</surname><given-names>V.</given-names></name><name><surname>Pasut</surname><given-names>A.</given-names></name><name><surname>Carmeliet</surname><given-names>P.</given-names></name></person-group><article-title>COVID-19: the vasculature unleashed</article-title><source>Nat. Rev. Immunol.</source><year>2020</year></element-citation></ref><ref id="bib75"><element-citation publication-type="journal" id="sref75"><person-group person-group-type="author"><name><surname>Utomo</surname><given-names>R.Y.</given-names></name><name><surname>Ikawati</surname><given-names>M.</given-names></name><name><surname>Meiyanto</surname><given-names>E.</given-names></name></person-group><article-title>Revealing the potency of citrus and galangal constituents to halt SARS-CoV-2 infection</article-title><source>Preprints. Org.</source><year>2020</year><fpage>1</fpage><lpage>8</lpage></element-citation></ref><ref id="bib76"><element-citation publication-type="journal" id="sref76"><person-group person-group-type="author"><name><surname>Walls</surname><given-names>A.C.</given-names></name><name><surname>Park</surname><given-names>Y.J.</given-names></name><name><surname>Tortorici</surname><given-names>M.A.</given-names></name><name><surname>Wall</surname><given-names>A.</given-names></name><name><surname>McGuire</surname><given-names>A.T.</given-names></name><name><surname>Veesler</surname><given-names>D.</given-names></name></person-group><article-title>Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein</article-title><source>Cell</source><year>2020</year></element-citation></ref><ref id="bib77"><element-citation publication-type="journal" id="sref77"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J.H.</given-names></name><name><surname>Luan</surname><given-names>F.</given-names></name><name><surname>He</surname><given-names>X.D.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>M.X.</given-names></name></person-group><article-title>Traditional uses and pharmacological properties of Clerodendrum phytochemicals</article-title><source>J.&#x000a0;Tradit. Complementary Med.</source><volume>8</volume><issue>1</issue><year>2017</year><fpage>2438</fpage></element-citation></ref><ref id="bib78"><element-citation publication-type="book" id="sref78"><person-group person-group-type="author"><name><surname>World Health Organization</surname></name></person-group><chapter-title>Novel Coronavirus 2019</chapter-title><year>2020</year><comment>Retrieved from</comment><ext-link ext-link-type="uri" xlink:href="https://www.who.int/emergencies/diseases/novel-coronavirus-2019" id="intref0010">https://www.who.int/emergencies/diseases/novel-coronavirus-2019</ext-link></element-citation></ref><ref id="bib79"><element-citation publication-type="journal" id="sref79"><person-group person-group-type="author"><name><surname>Wrapp</surname><given-names>D.</given-names></name><name><surname>Wang</surname><given-names>N.</given-names></name><name><surname>Corbett</surname><given-names>K.S.</given-names></name><name><surname>Goldsmith</surname><given-names>J.A.</given-names></name><name><surname>Hsieh</surname><given-names>C.L.</given-names></name><name><surname>Abiona</surname><given-names>O.</given-names></name></person-group><article-title>Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation</article-title><source>Science</source><volume>367</volume><year>2020</year><fpage>1260</fpage><lpage>1263</lpage><pub-id pub-id-type="pmid">32075877</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal" id="sref80"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>C.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>P.</given-names></name><name><surname>Zhong</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name></person-group><article-title>Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods</article-title><source>Acta Pharm. Sin. B</source><year>2020</year></element-citation></ref><ref id="bib81"><element-citation publication-type="journal" id="sref81"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Xiao</surname><given-names>Q.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>M.Y.</given-names></name><name><surname>Pan</surname><given-names>J.Y.</given-names></name><name><surname>Yang</surname><given-names>M.H.</given-names></name></person-group><article-title>Natural products from true mangrove flora: source, chemistry and bioactivities</article-title><source>Nat. Prod. Rep.</source><volume>25</volume><issue>5</issue><year>2008</year><fpage>955</fpage><lpage>981</lpage><pub-id pub-id-type="pmid">18820760</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal" id="sref82"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>W.H.</given-names></name><name><surname>Chen</surname><given-names>T.Y.</given-names></name><name><surname>Lu</surname><given-names>R.W.</given-names></name><name><surname>Chen</surname><given-names>S.T.</given-names></name><name><surname>Chang</surname><given-names>C.C.</given-names></name></person-group><article-title>Benzoxazinoids from <italic>Scoparia dulcis</italic> (sweet broomweed) with antiproliferative activity against the DU-145 human prostate cancer cell line</article-title><source>Phytochemistry</source><volume>83</volume><year>2012</year><fpage>110</fpage><lpage>115</lpage><pub-id pub-id-type="pmid">22944352</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal" id="sref83"><person-group person-group-type="author"><name><surname>Xia</surname><given-names>S.</given-names></name><name><surname>Zhu</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>M.</given-names></name><name><surname>Lan</surname><given-names>Q.</given-names></name><name><surname>Xu</surname><given-names>W.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name></person-group><article-title>Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein</article-title><source>Cell. Mol. Immunol.</source><year>2020</year><fpage>1</fpage><lpage>3</lpage></element-citation></ref><ref id="bib84"><element-citation publication-type="journal" id="sref84"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>P.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Feng</surname><given-names>J.</given-names></name><name><surname>Zhou</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name></person-group><article-title>Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission</article-title><source>Sci. China Life Sci.</source><volume>63</volume><year>2020</year><fpage>457</fpage><lpage>460</lpage><pub-id pub-id-type="pmid">32009228</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal" id="sref85"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>L.C.</given-names></name><name><surname>Hsieh</surname><given-names>C.C.</given-names></name><name><surname>Lin</surname><given-names>W.C.</given-names></name></person-group><article-title>Characterization and immunomodulatory activity of rice hull polysaccharides</article-title><source>Carbohydr. Polym.</source><volume>124</volume><year>2015</year><fpage>150</fpage><lpage>156</lpage><pub-id pub-id-type="pmid">25839805</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal" id="sref86"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Y.C.</given-names></name><name><surname>Lim</surname><given-names>M.Y.</given-names></name><name><surname>Lee</surname><given-names>H.S.</given-names></name></person-group><article-title>Emodin isolated from <italic>Cassia obtusifolia</italic> (Leguminosae) seed shows larvicidal activity against three mosquito species</article-title><source>J.&#x000a0;Agric. Food Chem.</source><volume>51</volume><issue>26</issue><year>2003</year><fpage>7629</fpage><lpage>7631</lpage><pub-id pub-id-type="pmid">14664519</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal" id="sref87"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>M.S.</given-names></name><name><surname>Lee</surname><given-names>J.</given-names></name><name><surname>Lee</surname><given-names>J.M.</given-names></name><name><surname>Kim</surname><given-names>Y.</given-names></name><name><surname>Chin</surname><given-names>Y.W.</given-names></name><name><surname>Jee</surname><given-names>J.G.</given-names></name><name><surname>Jeong</surname><given-names>Y.J.</given-names></name></person-group><article-title>Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13</article-title><source>Bioorg. Med. Chem. Lett</source><volume>22</volume><issue>12</issue><year>2012</year><fpage>4049</fpage><lpage>4054</lpage><pub-id pub-id-type="pmid">22578462</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal" id="sref88"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>G.</given-names></name><name><surname>Chen</surname><given-names>S.</given-names></name><name><surname>Chen</surname><given-names>Z.</given-names></name></person-group><article-title>Advances in COVID-19: the virus, the pathogenesis, and evidence-based control and therapeutic strategies</article-title><source>Front. Med.</source><volume>14</volume><issue>2</issue><year>2020</year><fpage>117</fpage><lpage>125</lpage><pub-id pub-id-type="pmid">32318975</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal" id="sref89"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Hou</surname><given-names>Y.</given-names></name><name><surname>Shen</surname><given-names>J.</given-names></name><name><surname>Huang</surname><given-names>Y.</given-names></name><name><surname>Martin</surname><given-names>W.</given-names></name><name><surname>Cheng</surname><given-names>F.</given-names></name></person-group><article-title>Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2</article-title><source>Cell Discov.</source><volume>6</volume><year>2020</year><fpage>14</fpage><pub-id pub-id-type="pmid">32194980</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal" id="sref90"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>N.</given-names></name><name><surname>Zhang</surname><given-names>D.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Yang</surname><given-names>B.</given-names></name><name><surname>Song</surname><given-names>J.</given-names></name></person-group><article-title>A&#x000a0;novel coronavirus from patients with pneumonia in China, 2019</article-title><source>N.&#x000a0;Engl. J. Med.</source><volume>382</volume><issue>8</issue><year>2020</year><fpage>727</fpage><lpage>733</lpage><pub-id pub-id-type="pmid">31978945</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal" id="sref91"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>T.</given-names></name><name><surname>Row</surname><given-names>K.H.</given-names></name></person-group><article-title>Box-Behnken design for optimizing extraction of luteolin from celery leaves</article-title><source>J.&#x000a0;Liq. Chromatogr. Relat. Technol.</source><volume>34</volume><issue>12</issue><year>2011</year><fpage>1036</fpage><lpage>1049</lpage></element-citation></ref><ref id="bib92"><element-citation publication-type="journal" id="sref92"><person-group person-group-type="author"><name><surname>Zuo</surname><given-names>A.X.</given-names></name><name><surname>Wan</surname><given-names>C.P.</given-names></name><name><surname>Zheng</surname><given-names>X.</given-names></name><name><surname>Rao</surname><given-names>G.X.</given-names></name></person-group><article-title>Chemical constituents of <italic>Elephantopus scaber</italic></article-title><source>Chem. Nat. Compd.</source><volume>52</volume><issue>3</issue><year>2016</year><fpage>484</fpage><lpage>486</lpage></element-citation></ref><ref id="bib93"><element-citation publication-type="journal" id="sref93"><person-group person-group-type="author"><name><surname>Zou</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>K.</given-names></name><name><surname>Zou</surname><given-names>J.</given-names></name><name><surname>Han</surname><given-names>P.</given-names></name><name><surname>Hao</surname><given-names>J.</given-names></name><name><surname>Han</surname><given-names>Z.</given-names></name></person-group><article-title>Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection</article-title><source>Front. Med.</source><year>2020</year></element-citation></ref></ref-list></back></article>